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ABSTRACT 
Integration of BMP and Insulin/IGF-1 Signaling 
Regulates Multiple Homeostatic Functions 
in Caenorhabditis elegans 
by 
James Fredrick Clark 
Advisor: Dr. Cathy Savage-Dunn 
The maintenance of homeostatic functions is key to the survival and well-being of an organism.  
Regulation of homeostasis relies on varied inputs, both intrinsic and extrinsic, to potentiate a web 
of interconnected signaling relays.  Insulin/IGF-1 signaling (IIS) is a well-known regulator of 
glucose and lipid metabolism, as well as having far reaching effects in other homeostatic 
mechanisms.  On the other hand, bone morphogenetic protein (BMP), a member of the 
transforming growth factor beta signaling superfamily, is known for its role in differentiation and 
development, with only recent studies highlighting potential roles in metabolic homeostasis.  
Here we elucidate new functions for C. elegans DBL-1/BMP signaling in regulating homeostasis 
through interaction with DAF-2/IIS via three distinct patterns of interaction.  First, we show that 
both pathways can work independently, as seen in the regulation of body size.  Second, we show 
that the two pathways can work via an epistatic relationship; DBL-1/BMP functions upstream of 
DAF-2/IIS to influence intestinal lipid stores through the regulation of ins-4.  Lastly, we identify 
an antagonistic mode of interaction where DBL-1/BMP can interact with DAF-2/IIS downstream 
of daf-2/InsR through changes in the localization of SKN-1.  Together, these data highlight 
various means by which both DBL-1/BMP and DAF-2/IIS can co-regulate homeostatic functions 
in C. elegans.  The complexity and redundancy found in many mammalian pathways proves a 
difficult hurdle in elucidating mechanisms of interaction.  Here we provide a model to further 
study the interactions of BMP and IIS to provide insight into human homeostasis. 
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1. Introduction 
1.A. C. elegans as a model 
     1.A.i. C. elegans growth 
Caenorhabditis elegans (C. elegans) is a microscopic, free-living nematode that can be 
easily cultivated on petri dishes plated with Escherichia coli (E. coli) as a food source and can be 
maintained at a range of temperatures, usually from 15°C to 25°C.  C. elegans contain two sexes, 
hermaphrodites and males, which develop through four larval stages (L1 – L4) before achieving 
sexual maturation (Brenner 1974) (Figure 1.1).  Once reaching adulthood, C. elegans 
hermaphrodites begin laying self-fertilized eggs.  The average lifespan of an adult C. elegans is 
approximately 20 days.  Progression from fertilized egg to egg-laying adult takes approximately 
3.5 days when grown at 20°C, however, the rate of development from egg to mature adult is 
dependent on environmental temperature; higher temperatures speed up development, while 
lower temperatures slow down development (Byerly et al. 1976; Corsi et al. 2015).  During 
development, if stressful conditions are detected, such as overcrowding or lack of food, an 
alternative larval stage called dauer is induced.  L2 larval animals exposed to these conditions 
will progress into the dauer larval stage rather than to the L3 larval stage (Cassada and Russell 
1975).   
The initial signals that induce dauer formation are actually received during the late L1 
larval stage.  This initiates development into a pre-dauer stage referred to as L2d.  If living 
conditions are conducive to growth, the L2d larvae will progress normally into the L3 stage.  
However if stressful conditions are present through the L2d larval stage, the larvae will develop 
into full-fledged dauers (Cassada and Russell 1975) (Figure 1.1).  Dauer larvae are a distinct 
INTRODUCTION 
2 
 
larval stage with a multitude of physiological changes.  Dauer larvae are much more resilient to 
harsh conditions than their non-dauer counterparts.  A thickened cuticle surrounds the body and 
plugs the mouth of the animal, providing protection from external elements (Cassada and Russell 
1975; Albert et al. 1981).  The body shrinks in volume and appears thin and elongated compared 
to L3 larvae.  Plugging of the mouth prevents eating, so the dauer larvae survive off of internal 
stores of food, built up prior to dauer induction as well as through increased autophagy 
(Meléndez et al. 2003).  Dauer larvae are mainly dormant, greatly restricting their movement to 
preserve energy.  Dauers can survive for months without food and when reintroduced to a food 
source, dauer larvae will continue development into a slightly modified L4 larval stage followed 
by adulthood (Hu 2007). 
     1.A.ii. C. elegans genetics 
 1.A.ii.a. Significance as a genetic model 
C. elegans are a mainly diploid organism containing five pairs of autosomal 
chromosomes and one sex chromosome (X); hermaphrodites have two X’s, males have one X.  
Hermaphrodites produce their own sperm, in addition to eggs, and can self-fertilize to create 
offspring.  However, male sperm can be used for fertilization post-mating.  This uniquely allows 
for the maintenance of genetically identical stocks through isolation of the hermaphrodites, while 
also providing a means of genetic manipulation through breeding (Brenner 1974; Corsi et al. 
2015).   
Mutations induced in P0 hermaphrodites can also be easily segregated through self-
fertilization, as homozygous mutants can be isolated in the F2 generation (Brenner 1974).  
Genetic manipulation in C. elegans can be accomplished through the use of various mutagenic 
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agents, site-specific modification such as CRISPR/Cas9 (Frokjaer-Jensen 2013), and RNA 
interference (RNAi) (Fire et al. 1998).  In addition, the C. elegans genome has been completely 
sequenced and partially annotated, allowing for rapid forward and reverse genetic approaches.  
These factors make C. elegans an ideal candidate for studying classical genetic interactions 
(Corsi et al. 2015). 
1.A.ii.b. C. elegans genetic nomenclature 
C. elegans genes are indicated by three letters, a hyphen, and a number; all lowercase 
italicized.  The corresponding protein to that gene is indicated by the same letters and number, 
only non-italicized uppercase.  For example, dbl-1 refers to the gene that produces the protein 
DBL-1 (Tuli et al. 2018). 
     1.A.iii. C. elegans tissues 
1.A.iii.a. Overview 
C. elegans are a simple, yet complex organism with distinct tissue types.  The outermost 
tissue of the animals is the hypodermis, a single-layer epidermis.  A cuticle is secreted from the 
hypodermis and acts as a protective barrier for the animal.  The cuticle is an extracellular matrix 
comprised of collagen, lipids, and glycoproteins.  Molting of the cuticle between each larval 
stage is necessary to allow for continued growth.  The hypodermis is a multinucleated syncytium 
formed during embryonic development.  The hypodermis plays an important role in cuticle 
formation and maintenance, innate immunity, and cell signaling.  Beneath the hypodermis is 
located the muscle tissue.  The muscle is anchored to the cuticle through the hypodermis, as 
such; mutations in cuticle formation prevent proper contraction of the muscle and disrupt the 
movement of the animals.  Running along the central length of the worm is the alimentary 
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system.  This system is comprised of the pharynx and intestine.  The pharynx is a mechanical 
pump that grinds food before it enters the intestine.  The intestine is the main digestive tissue of 
C. elegans and expresses metabolic proteins to both process and store nutrients.  Located beside 
the intestine at the center of the body is the somatic gonad that houses the germline.  The 
anatomy of the gonad is dependent upon the sex of the animal; the hermaphroditic gonad 
consists of two U-shaped arms, while the male gonad consists of only one U-shaped arm.  Each 
arm contains a population of gametocytes that progress through development as they travel the 
length of the arm.  Lastly, C. elegans contain a complex nervous system comprised of over 300 
neurons.  Major hubs of nerve ganglia exist near the head and tail regions of the animal, with the 
dorsal and ventral nerve cords serving as the main tracts along the length of the body (Corsi et al. 
2015).   
The presence of distinct tissue types is a boon as a model organism.  Alongside a 
completely sequenced genome, the identification of components and regulators involved in cell-
to-cell signaling can be examined both within and between tissues in a simpler genetic 
background.  In addition, the lack of pigmented tissue allows for ease of visualization of both 
fluorescent markers and dyes, making C. elegans and ideal candidate for studying intracellular 
localization (Corsi et al. 2015). 
1.A.iii.b. Hypodermis 
The majority of the hypodermis is comprised of 11 syncytial cells, hyp1 through hyp11.  
Hyp1 through hyp3 form the interfacial region of the mouth.  Hyp4 through hyp6 form the outer-
surface of the head region.  Hyp8 through hyp11 are responsible for the outer-surface of the tail 
region.  Hyp7, the largest by far of the hypodermal syncytium, runs the length of the worm from 
head to tail.  Throughout larval development, 23 hyp7 precursor cells are fused to form the 
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mature hyp7 syncytium which contains 139 nuclei at adulthood.  The large amount of DNA in 
hyp7 allows for the vast increase in size during larval development and adult life, presumably 
through increased transcription (Altun and Hall 2009c). 
Running alongside hyp7 in adult worms are two seam cells, located 180° from each 
other.  During larval development, seam cells exist as multiple individual cells.  These cells 
undergo multiple rounds of asymmetrical division; one daughter undergoes endoreduplication 
and fuses with hyp7, while the other daughter remains unfused.  During the L4 larval stage, the 
seam cells undergo a final round of asymmetrical division and then fuse into a syncytium, one on 
each side of the worm running laterally (Altun and Hall 2009c). 
1.A.iii.c. Intestine 
The intestine is responsible for the digestion and absorption of nutrients from food.  The 
tissue is comprised of 20 polyploid cells arranged as rings; the first ring containing four cells, 
with 9 subsequent rings containing two cells each.  The rings surround the intestinal lumen, 
through which food passes while being digested.  Each intestinal cell is polarized, containing a 
basolateral surface that faces the body cavity and an apical surface that faces the lumen.  The 
apical surface contains numerous microvilli that interact with the contents of the intestinal lumen 
(McGhee 2007; Altun and Hall 2009b; Altun and Hall 2009a). 
While the intestine is the main site of digestion and nutrient acquisition, it also plays 
numerous roles that affect the overall physiology of the animal.  As C. elegans does not have 
dedicated adipose tissue, the intestine is involved in lipid uptake, processing, and storage.  This 
results in the intestine being used as the main site for energy storage.  In hermaphrodites, yolk 
production is another key role undertaken by the intestine.  Vitellogenin proteins are synthesized 
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from nutrients in the intestine and transported to developing embryos.  The intestine has also 
been implicated as a site of stress and pathogen response, due to the propensity to intake toxins, 
chemical stressors, and pathogens through eating.  Finally, the intestine is thought to play a 
central role in aging through multiple actions, such as dietary restriction, the aforementioned 
stress response, germline interaction, and as a site for DAF-2/Insulin/IGF-1 signaling-dependent 
aging response (McGhee 2007; Altun and Hall 2009a; Altun and Hall 2009b). 
1.A.iii.d. Neurons 
While relatively simple, C. elegans neuronal circuitry provides the ability to respond to a 
variety of stimuli, social feeding behavior, rudimentary learning, and the complex mating 
behavior in males.  An adult hermaphrodite contains 302 neurons, while a male contains 383.  
The male neuronal system is less understood than that of the hermaphrodite and will not be 
discussed in further detail.  The majority of neurons are found in either: the nerve ring, encircling 
the pharynx; the two nerve chords running the length of the animal, either dorsal or ventral; or 
the neurophil, located in the tail (Brenner 1974; White et al. 1986; Altun and Hall 2011; Corsi et 
al. 2015). 
The neurons can be classified into four different categories based on function; motor, 
interneurons, sensory, or polymodal.  Motor neurons provide the circuitry to regulate the 
locomotive behavior of the worm.  Interneurons function as information processors and relay 
inputs and outputs to other neurons.  Sensory neurons provide the ability to detect stimuli in the 
environment, which include chemosensors, odorsensors, oxygen sensors, nociceptors, 
osmoceptors, thermosensors, mechanosensors, and proprioceptors.  The variety of sensory inputs 
found in C. elegans has allowed them to develop complex signaling responses to both external 
and internal stimuli; the presence of other worms coupled with food detection can trigger 
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increased pharyngeal activity, decreased roaming, and nutrient mobilization.  Lastly, polymodal 
neurons are those that perform multiple functions, such as the M3 neurons that perform both 
motor and sensory function in the pharynx (Altun and Hall 2011). 
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Figure 1.1. The life cycle of Caenorhabditis elegans.  C. elegans progress through four larval 
stages, L1, L2, L3, and L4, before reaching adulthood.  The normal developmental period from 
egg to egg-laying adult takes just over two days at 20°C.  If animals are hatched in the absence of 
food, L1 larvae will go into an arrested state until reintroduced to a food source.  Alternatively, if 
animals are subjected to stress during the transition from L1 to L2, they will develop into dauer 
larvae, an alternative L3 stage that is highly resistance to external stressors and can survive 
without food for months.  Once reintroduced to suitable conditions, dauer larvae will develop 
into L4 animals and continue to adulthood.  Figure borrowed from (Altun and Hall 2009d). 
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1.B. TGF-β Superfamily Signaling 
     1.B.i. Overview of TGF-β Signaling 
 The Transforming Growth Factor beta (TGF-β) superfamily is a family of signal 
transduction ligands that are responsible for a vast number of highly conserved functions in 
development, growth, and maintenance.  The superfamily consists of TGF-βs, Activins, growth 
differentiation factors (GDFs), Nodal, and bone morphogenetic proteins (BMPs).  Conservation 
of these signaling pathways can be found in organisms ranging from C. elegans to humans, who 
contain over 40 ligands (Shi and Massague 2003; Wu and Hill 2009). 
 Active TGF-β ligands are mainly secreted as homodimers, though heterodimers have 
been shown in a few cases.  Signal transduction is initiated by the binding of a dimerized ligand 
to a set of receptors.  The transmembrane receptors are type I and type II serine/threonine kinases 
located on the outer surface of the cell membrane.  A class of proteins referred to as ligand traps 
also exist as a method to regulate ligand availability.  Ligand traps function by binding to the 
active ligand and sequestering it from its respective receptors, attenuating the signaling 
transduction (Shi and Massague 2003; Wu and Hill 2009). 
Initial binding of the ligand to one receptor allows for the recruitment of the other, 
bringing two type I and two type II receptors into contact.  This proximity allows the 
intracellular domain of the type II receptors to phosphorylate the type I receptors.  A variety of 
type I and type II receptors exist and the diversity of responses to TGF-β signaling can be 
attributed to varied pairs of receptors exhibiting specificity for particular ligands (Shi and 
Massague 2003; Wu and Hill 2009). 
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Once the type I receptor is activated, it can phosphorylate and activate the intracellular 
Smad proteins.  Smad proteins exist as three different classes: receptor Smads (R-Smad), co-
mediator Smads (Co-Smad), and inhibitory Smads (I-Smad).  The type I receptor directly 
phosphorylates the R-Smads, which can then recruit a Co-Smad.  I-Smads are able to prevent the 
activation of R-Smads through multiple mechanisms, such as competitive binding to R-Smads or 
Co-Smads.  Active heterotrimeric complexes are formed between two R-Smads and a Co-Smad 
and shuttled into the nucleus.  Once in the nucleus, this complex is able to recruit additional 
cofactors and regulate the transcription of target genes (Shi and Massague 2003; Wu and Hill 
2009). 
     1.B.ii. BMP Signaling 
 The role of BMPs in embryonic development has been well characterized.  In Drosophila 
melanogaster (Drosophila), the initial dorsal-ventral axis of developing embryos is dictated by 
the BMP2/4 homolog Decapentaplegic (Dpp), which forms a gradient.  Cells within the embryo 
respond to the varying levels of Dpp to induce differentiation (Teleman and Cohen 2000).  In 
Xenopus laevis (Xenopus) Bmp4 expression induces a ventral fate, requiring the Spemann 
organizer to express BMP antagonists, such as Chordin and Noggin, to limit BMP signaling to 
the ventral side of the embryo (De Robertis and Kuroda 2004).  Similar regulation of Bmp2b and 
Bmp7 has been shown in Danio rerio (zebrafish) .  Across species, BMP plays a conserved role 
in axis development (Little and Mullins 2006). 
 Historically, bone morphogenetic proteins (BMPs) were identified for their ability to 
induce bone formation in non-skeletal tissue (Urist 1965; Urist and Strates 1971).  Multiple BMP 
ligands have been shown to play pivotal roles in limb development, endochondral bone 
development, and post-natal skeletal homeostasis. Bmp2, Bmp4, and Bmp7 expression at the 
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apical ectodermal ridge of budding limbs plays an important role in digit patterning.  Conditional 
knock-out studies show that coordination of Bmp2 and Bmp4 is required for osteoblastogenesis 
and regulation of chondrocytes.   In addition to the ligands, the three type I BMP receptors 
(BMPR1A/ALK3, BMPR1B/ALK6, and ACVR1/ALK2) exhibit similar function in 
endochondral bone development, bone growth plate dynamics, and adult bone homeostasis.  
Together, these findings implicated BMP signaling as a major regulator of bone development 
and maintenance (Salazar et al. 2016). 
     1.B.iii. TGF-β Signaling in C. elegans 
 1.B.iii.a. daf-7/TGF-β 
 The gene daf-7 is the C. elegans homolog of human TGF-β (Ren et al. 1996).  The 
pathway consists of the ligand DAF-7, type II receptor DAF-4 (Estevez et al. 1993), type I 
receptor DAF-1 (Georgi et al. 1990), R-Smads DAF-8 (Park et al. 2010) and DAF-14 (Inoue and 
Thomas 2000), and Co-Smad DAF-3 (Patterson et al. 1997).  Originally, DAF-7 was thought to 
be expressed only in the ASI sensory neurons in response to food availability and pheromones 
(Ren et al. 1996), however, recent studies have shown expression in the ASJ neurons in response 
to pathogenic bacteria (Meisel et al. 2014).  The receptors of the pathway are found throughout 
the body.  The DAF-7 signaling pathway was originally identified for its dauer constitutive (daf-
c) phenotype, but has been implicated in multiple physiological roles such as lifespan, 
metabolism, and behavior (Hu 2007). 
 1.B.iii.b. dbl-1/BMP 
 The gene decapentalplegic/BMP-like-1 (dbl-1) is a C. elegans BMP homolog most 
closely related to human BMP2/4.  The pathway consists of the ligand DBL-1 (Suzuki et al. 
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1999), type II receptor DAF-4 (shared with the DAF-7 pathway) (Estevez et al. 1993), type I 
receptor SMA-6 (Krishna et al. 1999), R-Smads SMA-2 and SMA-3, and Co-Smad SMA-4 
(Savage et al. 1996) (Figure 1.2).  DBL-1 is expressed in multiple neurons, while SMA-6 and 
SMA-3 are expressed only in the hypodermis, pharynx, and intestine.  The initial identification 
of dbl-1 was through its small body size and abnormal male tail phenotypes (Suzuki et al. 1999; 
Gumienny and Savage-Dunn 2013). 
 Continued study of DBL-1 signaling has shown it to be a major regulator of body size.  
DBL-1 acts in a dose-dependent manner, where a reduction in signaling results in small body 
size, while increased signaling results in long body size (Suzuki et al. 1999).  This effect is 
thought to function through alteration of cell size, as cell count is not altered in dbl-1 mutants 
(Nagamatsu and Ohshima 2004).  Additionally, tissue-specific expression of SMA-3 has shown 
that SMAD signaling in the hypodermis is sufficient to promote normal body size (Wang et al. 
2002).  Multiple collagen genes, such as rol-6, col-41, col-141, and col-142, are known targets of 
the DBL-1 pathway and are thought to be the major downstream effectors of body size (Liang et 
al. 2007; Roberts et al. 2010; Yin et al. 2015; Madaan et al. 2017).  In addition to body size, the 
DBL-1 pathway also plays a role in cell fate specification, mainly through affecting male tail ray 
identity (Suzuki et al. 1999) and mesodermal patterning (Foehr et al. 2006).  Another important 
aspect of DBL-1 signaling is its role in innate immunity, as dbl-1 mutants exhibit increased 
susceptibility to pathogenic infection and DBL-1 activity promotes expression of pro-immunity 
factors (Mallo et al. 2002; Roberts et al. 2010). 
Multiple modulators of the DBL-1 signaling pathway have been identified.  LON-2 is a 
membrane bound glypican that acts as ligand trap that binds to DBL-1 to suppress signal 
transduction (Gumienny et al. 2007).  SMA-10 is a member of the leucine-rich repeats and 
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immunoglobulin-like domains (LRIG) family of proteins.  It has been shown to bind to both 
DAF-4 and SMA-6, and thought to facilitate DBL-1 signaling through intracellular trafficking 
and recycling of SMA-6 (Gumienny et al. 2010; Gleason et al. 2017).  DRAG-1 is a member of 
the repulsive guidance molecule (RGM) family, members of which have been shown to bind 
BMP ligands and receptors in other species.  DRAG-1 was shown to function in both body size 
regulation and mesodermal patterning through DBL-1 signaling (Tian et al. 2010).  A member of 
the cysteine-rich motor neuron protein (CRIM) family, CRM-1, is thought to function in 
facilitating the binding of DBL-1 to its receptors.  CRM-1 is expressed in the same neurons as 
DBL-1 and promotes signaling activity in the hypodermis (Fung et al. 2007; Gumienny and 
Savage-Dunn 2013) (Figure 1.2). 
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Figure 1.2. DBL-1 Signaling in C. elegans.  The secreted, dimerized ligand, DBL-1, binds to its 
receptors, DAF-4 and SMA-6, to induce SMAD signaling in the receiving cell.  The R-SMADs, 
SMA-2 and SMA-3, are phosphorylated and form a heterotrimer with the Co-SMAD, SMA-4.  
The activated SMAD complex is then translocated into the nucleus where it recruits co-factors, 
such as SMA-9, to regulate the transcription of target genes.  LON-2, CRM-1, and DRAG-1 act 
as modulators of the DBL-1 pathway.  Figure borrowed from (Gumienny and Savage-Dunn 
2013).  
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1.C. Insulin/IGF-1 Signaling 
     1.C.i. Mammalian Insulin/IGF-1 Signaling 
 Insulin is a member of the insulin/IGF/relaxin family of signaling peptides, and is 
evolutionarily conserved through numerous species.  Mammalian Insulin/IGF-1 signaling (IIS) is 
initiated by the binding of insulin (INS), the ligand, to the insulin receptor (InsR).  The InsR is 
composed of two α-subunits, which first bind INS, and then subsequently recruit two β-subunits, 
together forming an active INS/InsR complex.  Insulin receptor substrates 1 and 2 (IRS1/2) are 
then phosphorylated by the InsR complex and translocated into the cytoplasm where it 
subsequently activates the phosphotidylinositol-3-kinase (PI3K)/3-phosphoinositide-dependent 
protein kinase (PDK1)/protein kinase B (PKB/Akt) phosphorylation signaling cascade (Figure 
1.3) (Zhang and Liu 2014; Sah et al. 2016).   
 Activation of the PI3K/PDK1/Akt cascade results in a diverse range of interactions that 
regulate cellular metabolism.  Interaction of PDK1 and glycogen synthase kinase 3 (GSK3) 
promotes the production of glycogen.  Akt can promote the activation of mammalian target of 
rapamycin complex 1 (mTORC1) through the inactivation of the tuberous sclerosis complex 
(TSC1/2) (Manning et al. 2002), and control the activation or inactivation of a variety of 
transcription factors such as the forkhead box protein O1 (FOXO1), phosphodiesterase 3b 
(PDE3b), sterol regulatory element-binding proteins (SREBPs), and peroxisome proliferator-
activated receptor gamma co-activator 1-alpha (PGC1α).  IIS has also been shown to activate the 
mitogen-activated protein kinase (MAPK) cascade to aid in the regulation of proliferation and 
differentiation (Figure 1.3) (Armoni et al. 2006; Mauvoisin et al. 2007; Kousteni 2012; Xu et al. 
2013; Zhang and Liu 2014; Sah et al. 2016; Wang et al. 2016; Lee and Dong 2017). 
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 IIS plays a major role in regulating glucose homeostasis.  INS is secreted from pancreatic 
β cells, usually in response to high levels of glucose in the blood after food intake.  The secreted 
INS functions in multiple tissues to facilitate the reduction of blood glucose.  In the liver, IIS 
blocks gluconeogenesis and promotes glycogen production and storage.  In adipose and skeletal 
muscle, IIS results in increased glucose uptake through increased glucose transporter type 4 
(GLUT4) activity (Figure 1.3).  IIS also acts as a positive feedback loop for itself, stimulating β 
cell proliferation and function.  IIS activity in the brain also contributes to system wide 
metabolism via regulation of energy intake and expenditure through interactions with various 
signaling networks (Nakae et al. 2008; Lu et al. 2012; Zhang and Liu 2014; Luo and Liu 2016; 
Marzetti et al. 2016; Titchenell et al. 2017). 
     1.C.ii. Insulin/IGF-1 Signaling in C. elegans 
 Unlike in mammals, there exist over 40 insulin-like peptides (ILPs) in C. elegans that act 
as the ligands for IIS.  These ILPs bind to DAF-2/IR, and can act as either agonists or antagonists 
depending on the specific ILP.  Binding of an agonistic ligand to DAF-2 activates AGE-1/PI3K 
which, in turn, utilizes the conversion of phosphatidylinositol 4,5-bisphosphate (PIP2) to 
phosphatidylinositol (3,4,5)-trisphosphate (PIP3) to activate PDK-1.  Once active, PDK-1 
subsequently activates AKT-1 and AKT-2.  Lastly, AKT-1/2 phosphorylates transcription factors 
that directly regulate gene expression of IIS targets.  The most well-characterized transcription 
factor, DAF-16/FOXO, is excluded from the nucleus when phosphorylated by AKT-1/2; 
however, localization of additional transcription factors such as SKN-1 and PQM-1 are regulated 
as well (Kimura et al. 1997; Ogg et al. 1997; Gems et al. 1998; Paradis and Ruvkun 1998; 
Tissenbaum and Ruvkun 1998; Lin et al. 2001; Pierce et al. 2001; Tullet et al. 2008; Tepper et al. 
2013).   
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 The initial discover of the DAF-2 pathway was through the study of dauer induction; with 
daf-2 receiving its name from the phenotype abnormal dauer formation.  daf-2 mutations are all 
partial loss-of-function, as null mutations are lethal.  The abnormal dauer phenotype is 
temperature sensitive, with daf-2 mutants exhibiting constitutive dauer formation (daf-c) at 25°C.  
Continued study of DAF-2/IIS has elucidated its role in a wide range of physiological functions 
in C. elegans; daf-2 mutants exhibit a range of phenotypes relating to stress response, nutrient 
homeostasis, aging, reproduction, and growth (Kimura et al. 1997; Gems et al. 1998; Tissenbaum 
and Ruvkun 1998; Meléndez et al. 2003). 
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Figure 1.3. Wide reaching effects of Insulin/IGF-1 Signaling.  IIS is a prolific regulator of cell 
function, controlling numerous vital processes in various tissues.  Activation of InsR by ILPs 
results in the activation of broad downstream effects.  The PI3K cascade directly affects glucose 
uptake to regulate glycogen synthesis alongside GSK3.  Active Akt results in numerous effects, 
including the activation of TORC1 and inhibition of FOXO.  IIS also plays a role in activating 
the RAS/RAF/MEK/ERK kinase pathway.  Figure borrowed from (Zhang and Liu 2014). 
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1.D. Lipid Metabolism 
     1.D.i. Mammalian Lipid Metabolism 
 I.D.i.a. Adipose Tissue 
 Adipose tissue functions as the main site of energy storage in mammals, however, it can 
also function as an endocrine organ through the secretions of numerous hormones and 
adipokines involved in the regulation of metabolism across tissues.  There exist two types of 
adipose tissue, white adipose tissue (WAT) and brown adipose tissue (BAT), each with their own 
distinct physiological functions (Luo and Liu 2016; Chu and Gawronska-Kozak 2017).   
 WAT is characterized by adipocytes that contain a large, central lipid droplet that 
composes the majority of the volume of the cell.  These adipocytes also contain relatively few 
mitochondria and function mainly in lipid storage and production of leptin, a hormone that plays 
a role in the regulation of hunger.  WAT is found predominantly near the abdomen, thighs, and 
waist as subcutaneous tissue and arises from differentiation of the mesenchymal cell lineage 
lacking the expression of MYF5 (Timmons et al. 2007; Luo and Liu 2016; Jeremic et al. 2017). 
 BAT is strikingly different than WAT, with adipocytes containing numerous, small lipid 
droplets surrounded by a plethora of mitochondria.  BAT has been shown to play a role in 
thermogenesis through the use of uncoupling protein-1 (UCP1).  UCP1 functions by uncoupling 
ATP production from the electron transport chain, resulting in the production of heat (Cannon 
and Nedergaard 2004).  BAT is predominantly found in perivascular, epicardial, supra-adrenal, 
and supra-scapular regions and arises from the MYF5-expressing mesenchymal cell lineage, 
similar to that of skeletal muscle (Timmons et al. 2007).  Recent studies have shed light on a 
process known as browning, or beiging, of fat, where WAT is converted into pseudo-brown 
INTRODUCTION 
20 
 
(brite/beige) adipose tissue; exhibiting characteristics that are normally associated with BAT, 
such as increased mitochondria and decreased lipid stores (Chu and Gawronska-Kozak 2017).  
The exact mechanisms by which this conversion occurs are not known, however it has been 
observed after weight loss, exercise, and cold stimulus, with multiple TGF-β family ligands 
implicated (Zamani and Brown 2011; Yu et al. 2015; Grgurevic et al. 2016; Luo and Liu 2016; 
Marzetti et al. 2016; Jeremic et al. 2017; Ng et al. 2017).   
 1.D.i.b. Insulin and Mechanistic Target of Rapamycin 
 IIS plays a large role in the regulation of lipid metabolism in multiple tissues.  When 
blood INS levels are high, IIS induces glucose uptake in adipose tissue to facilitate the 
conversion of glucose into fatty acids while blocking lipolysis.  Simultaneously, increased IIS 
activity blocks glucose production and secretion from the liver while promoting glycogen 
synthesis and storage.  These tissue specific-effects are accomplished through the regulation of 
numerous downstream effectors, mainly through the activation of the PI3K/PDK1/Akt cascade 
(Nakae et al. 2008; Kousteni 2012; Zhang and Liu 2014).   
FOXO1, one of the well-studied effectors of IIS, acts to suppress adipogenesis through 
multiple actions.  During early stages of adipocyte differentiation, FOXO1 is inactivated via 
phosphorylation by Akt, allowing for proper adipogenesis (Nakae et al. 2003).  In mature 
adipocytes, FOXO1 represses the expression of peroxisome proliferator-activated receptor-
gamma (PPARγ) (Armoni et al. 2006), a transcription factor involved in promoting adipogenesis, 
and increases the expression and secretion of adiponectin, a pro-β-oxidation anti-
gluconeogenesis adipokine, in conjunction with C/enhancer-binding protein alpha (C/EBPα) 
(Qiao and Shao 2006).  Additionally, FOXO1 has been shown to positively regulate the 
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expression of adipose triglyceride lipase (ATGL), an initial step in lipid β-oxidation (Nakae et al. 
2008; Chakrabarti and Kandror 2009; Kousteni 2012; Lee and Dong 2017). 
In parallel to FOXO1, IIS also regulates β-oxidation through interaction with the β-
adrenergic pathway, a cAMP-PKA-dependent regulator of lipolysis.  Active IIS attenuates the β-
adrenergic pathway at multiple points.  First, IIS reduces cAMP levels by inhibiting adenylate 
cyclase through phosphorylation of adipose-specific phospholipase A2.  Second, IIS reduces 
PKA activity through the activation of PDE-3b, which again depletes cAMP levels, in response 
to phosphorylation by Akt.  Last, IIS stimulates activation of the mechanistic target of rapamycin 
(mTOR) pathway, which exhibits multiple effects on lipolysis and lipogenesis (Czech et al. 
2013). 
Converging on lipid metabolism with IIS at multiple points is the mTOR pathway.  
mTOR signaling is carried out through the formation of two distinct mTOR complexes, TORC1 
and TORC2.  Mammalian TORC1 forms through the association of mTOR, the regulatory-
associated protein of mTOR (Raptor), and mammalian LST8 (mLst8), with additional ancillary 
proteins completing the complex; meanwhile, mammalian TORC2 forms through the association 
of mTOR, the rapamycin-insensitive companion of mTOR (Rictor), mammalian Sin1 (mSin1) 
and mLst8 (Takahara and Maeda 2013; Antikainen et al. 2017).  IIS plays a direct role in the 
regulation of mTORC1, as active Akt/PKB inhibits TSC1/2 to activate mTORC1 (Manning et al. 
2002); conversely, mTORC1 can repress IIS activity through the activation of growth factor 
receptor bound protein 10 (Grb10), an inhibitor of IIS (Yu et al. 2011), and through increased 
phosphorylation of IRS-1 by  ribosomal protein S6 kinase beta-1 (S6K1), attenuating its 
association with InsR (Harrington et al. 2004).  The regulation of mTORC2 is less understood, 
however, PI3K activity has been show to activate mTORC2; mSin1 is able to bind to PIP3, 
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produced by active PI3K, recruiting mTORC2 to the plasma membrane and resulting in the 
phosphorylation of Akt (Liu et al. 2015).  The convergence of IIS and mTORC2 on Akt 
phosphorylation is thought to promote maximal kinase activity, as both pathways target separate 
residues.  Independently of IIS, mTORC1 can be down-regulated by the activity of adenosine 
monophosphate-activated protein kinase (AMPK), which acts to both promote TSC1/2 activity 
and inhibit the activity of Raptor through phosphorylation, in response to various stress 
conditions (Takahara and Maeda 2013; Antikainen et al. 2017). 
The two complexes exhibit distinct function as mTORC1 plays a role in mRNA 
translation, ribosome biogenesis, and autophagy, while mTORC2 plays a role in cell survival, 
AGC kinase phosphorylation, and actin organization.  However, both mTORC1 and mTORC2 
converge on the regulation of lipid synthesis (Takahara and Maeda 2013; Antikainen et al. 2017).  
Both complexes are thought to play a role in the up-regulation of SREBP-1c activity, a major 
regulator of lipid synthesis; mTORC1 is thought to regulate SREBP-1c through S6K1 activity 
and the inhibition of lipin 1, while mTORC2 is thought to promote SREBP-1c activity through 
Akt phosphorylation.  Additionally, mTORC1 regulates lipid droplet activity by simultaneously 
up-regulating fat specific protein 27 (FSP27) (Puri et al. 2007), a lipid droplet binding protein in 
adipose tissue that promotes lipid accumulation, and blocking lipolysis by down-regulating 
ATGL (Chakrabarti et al. 2013). Recent studies suggest that mTORC2 can regulate glucose 
uptake in WAT to promote de novo lipogenesis through the activation of carbohydrate response 
element-binding protein (ChREBP) (Tang et al. 2016), a regulator of lipogenesis.  mTORC2 is 
similarly required for glucose uptake in BAT, however, rather than promoting lipogenesis, the 
glucose is used to drive thermogenesis upon cold exposure (Albert et al. 2016). 
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 1.D.i.c. TGF-β/BMP 
 A growing number of studies have begun to describe a role for the TGF-β signaling 
family in regulating lipid metabolism.  In mice, Gdf3 has been shown to directly impact the 
formation of WAT by acting as an adipogenic cytokine (Wang et al. 2004; Shen et al. 2009).  In 
addition, high levels of both inhibin beta B and TGFβ1 in adipose tissue have been correlated 
with obesity in humans (Fain et al. 2005; Sjoholm et al. 2006).  The receptor, BMPR1A, also 
provides a link between insulin and BMP signaling.  In humans, specific genetic variants of 
BMPR1A were associated with obesity, while in mice the loss of BMPR1A was able to improve 
insulin sensitivity in older mice (Bottcher et al. 2009; Schulz et al. 2016).  Recently, BMP7 was 
shown to stimulate glucose uptake through the PI3K/PDK-1/Akt kinase cascade alongside IIS, 
resulting in increased clearance of blood glucose in diabetic mice.  The same study also 
implicated BMP4 in insulin resistance by causing a serine phosphorylation in IRS1, preventing it 
from becoming active through interaction with InsR and reducing PI3K activation 
(Chattopadhyay et al. 2017).  Numerous roles have also been described for multiple BMPs and 
GDFs in adipogenesis, mainly through specifying progenitor cell fates, maintaining preadipocyte 
populations, and dictating terminal differentiation into mature adipocytes (Zamani and Brown 
2011).  Together, these studies illustrate the importance of the TGF-β signaling superfamily not 
only as regulators of early development, but major factors in the homeostatic maintenance of 
lipids. 
     1.D.ii. Lipid Droplet Dynamics 
 Lipid droplets (LDs) are organelles that function in the storage of lipids, and consist of a 
neutral lipid core, composed mainly of triacylglycerides (TAGs) and sterols, surrounded by a 
phospholipid monolayer.  LDs bud from the endoplasmic reticulum (ER) as the majority of TAG 
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precursors are synthesized in the ER.  While detailed regulation of LD budding from the ER is 
not fully understood, the current hypothesis is that a critical mass of neutral lipids form in the 
intermembrane space and are subsequently pinched off, forming a distinct organelle (Brasaemle 
and Wolins 2012). 
 The surface of LDs is bound by multiple classes of proteins that include structural, TAG 
synthesis, sterol synthesis, membrane trafficking, and lipase proteins.  The binding and 
regulation of each of these classes is dynamic and dependent on the current needs of the cell.  In 
addition, both peroxisomes and mitochondria can be found in close proximity to LDs, sometimes 
facilitated by protein complexes, to expedite the transfer of fatty acids for β-oxidation (Meex et 
al. 2009; Brasaemle and Wolins 2012; Yu et al. 2015). 
 The size of LDs can play a functional role in the cell.  The larger central droplet of white 
adipocytes is more efficient at storing lipids, while the increased surface area of multiple smaller 
droplets in brown adipocytes facilitates greater interactions with mitochondria.  LD size is 
regulated through either the addition of lipid content, or lipolysis, the breakdown of TAGs into 
free fatty acids (FFAs) (Suzuki et al. 2011; Brasaemle and Wolins 2012). 
 LDs can grow in two different manners.  The direct addition of neutral lipids to the core 
allows for expansion.  Evidence from C. elegans has shown that LDs may be transported back to, 
and dock at, the ER to receive additional contents.  Some lipid droplets also maintain contact 
with the ER after budding, and will continually grow.  A second mechanism for lipid droplet 
expansion is through the fusion of two individual droplets.  The production of phospholipids can 
be a limiting agent for lipid droplet growth, as increased volume requires additional surface area 
(Suzuki et al. 2011; Shi et al. 2013; Yu et al. 2015). 
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 The reduction in size of LD is achieved through the regulation of lipases.  TAGs are 
broken down using three lipases: adipose triacylglycerol lipase (ATGL/PNPLA2), hormone-
sensitive lipase (HSL/LIPE), and monoacylglycerol lipase (MAGL/MGLL).  Lipolysis occurs at 
the surface of the LD, with the binding of the lipases being tightly regulated.  When inactive, the 
lipases, ATGL and HSL, are localized to the cytoplasm; however, upon activation by protein 
kinase A (PKA), both lipases are recruited to the surface of the LD, resulting in the production of 
FFAs that are then shuttled to either mitochondria or peroxisomes for β-oxidation.  Continued 
lipolysis results in the reduction of lipid droplet mass (Meex et al. 2009; Suzuki et al. 2011; 
Brasaemle and Wolins 2012). 
     1.D.iii. Lipid Metabolism in C. elegans 
  Biosynthesis of complex lipids is dependent upon the Δ9 fatty acid desaturases, FAT-5, 
FAT-6, and FAT-7.  These desaturases perform the initial desaturation step of converting 
saturated fatty acids into polyunsaturated fatty acids (PUFAs); FAT-5 converts palmitic acid 
(16:0) to palmitoleic acid (16:1), while FAT-6 and FAT-7 convert stearic acid (18:0) to oleic 
acid (18:1).  Subsequent desaturations and elongations result in the production of 20 carbon 
PUFAs that are used for phospholipid production, sterol production, or storage in lipid droplets 
as TAGs.  While FAT-5 can partially compensate for FAT-6 and FAT-7, and vice versa, these 
processes are essential for viability, as fat-5;fat-6;fat-7 mutants are non-viable (Watts and 
Browse 2000; Brock et al. 2006; Brock et al. 2007; Shi et al. 2013).   
 Conversely, lipids are broken down for energy utilization via β-oxidation.  The initial 
conversion of TAGs to FFAs occurs on the membrane of lipid droplets, like that of mammals, 
starting with ATGL-1/PNPLA2 (Zhang et al. 2010a).  Lipid droplet protein 1 (LID-1) regulates 
the binding of ATGL-1 to lipid droplets through stimulation by PKA signaling, triggering the 
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ATGL/HSL/MAGL enzymatic pathway (Lee et al. 2014).  Oxidation of those FFAs then occurs 
in either the peroxisomes or mitochondria.  While synthesis is controlled by relatively few genes, 
lipid oxidation is controlled by a multitude, with over 100 predicted lipases in the C. elegans 
genome (Srinivasan 2015).  This has led to difficulty in fully understanding the web of β-
oxidation regulation, though certain branches have been studied.  The pathway of MAOC-
1/hydratase, DHS-28/dehydrogenase, and DAF-22/thiolase plays an important role in 
catabolizing FFAs in peroxisomes; mutations in these enzymes lead to animals with greatly 
increased lipid accumulation and droplet size (Zhang et al. 2010a). 
Regulation of lipids in C. elegans is achieved through the interaction of multiple, 
complex regulatory systems.  As the majority of saturated lipids are obtained from food sources, 
the regulation of pharyngeal pumping is a tightly regulated behavior.  The sensory neurons of the 
pharyngeal system respond to the presence of food by increasing the rate of food intake; 
mutations in eat-2, an acetylcholine receptor in pharyngeal muscle, result in reduced pumping 
and lipid stores (Raizen et al. 1995).  Serotonin plays a large role in pharyngeal activity, and is 
synthesized in response to available food.  The serotonin-mediated G-protein-coupled receptors, 
SER-1, SER-5, and SER-7, are directly involved in pharyngeal pumping behavior.  However, 
serotonin also exhibits a feeding-independent effect on lipid metabolism.  MOD-1, a serotonin-
gated chloride channel, regulates ATGL-1 activity in the intestine, directly altering lipid stores 
independent of food intake by increasing lipid β-oxidation in peroxisomes and mitochondria.  A 
similar result is seen in humans, where decreased body weight and lipid levels were observed in 
humans treated with a serotonin agonist (Smith et al. 2009; Chan et al. 2013).  DAF-7/TGF-β 
functions similarly to serotonin in the regulation of metabolism.  Depending on the presence of 
food, DAF-7 can regulate both pharyngeal pumping as well as lipid storage, albeit through 
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separate signals.  In the absence of food, DAF-7 promotes lipid storage through glutamate 
signaling (Greer et al. 2008).  In both cases, the ability to separate feeding behavior and lipid 
accumulation indicates that neuronal signaling plays an important role in directly regulating lipid 
homeostasis. 
DAF-2/IIS is another well-known regulator of lipid metabolism in C. elegans.  Much like 
in mammals, DAF-2/IIS regulates the localization of DAF-16/FOXO to control downstream 
metabolic processes.  Numerous genes integral for lipid metabolism, such as fat-6 and fat-7 (Ogg 
et al. 1997), as well as transcription factors involved in lipid metabolism, such as MDT-15 
(Zhang et al. 2013), are known targets of DAF-16/FOXO regulation.  Interestingly, the overall 
directionality of regulation seems to be reversed in C. elegans compared to mammals; in C. 
elegans DAF-16 promotes lipid accumulation, while in mammals FOXO promotes energy 
expenditure and impedes adipogenesis.  SBP-1/SREBP has also been shown to function 
downstream of DAF-2/IIS, as RNAi of sbp-1 suppresses the high-fat phenotype of daf-2 mutants 
(Ashrafi et al. 2003); SBP-1 functions in conjunction with MDT-15 to promote fatty acid 
desaturation (Yang et al. 2006).  In mammals, SREBP regulation is controlled in part through IIS 
effects on mTOR (Xu et al. 2013) 
C. elegans contains the two highly conserved TOR complexes, TORC1 and TORC2.  C. 
elegans TORC1 consists of LET-373/TOR, DAF-15/Raptor, and LST-8/mLst8, while TORC2 
consists of LET-373/TOR, RICT-1/Rictor, SINH-1/mSin1, and LST-8/mLst8.  Both TORC1 and 
TORC2 have been shown to regulate lipid homeostasis and metabolism, although they do so in 
opposite directions.  TORC1 is thought to promote lipid accumulation, as knockdown of ATX-2, 
an inhibitor of TORC1 activity analogous to mammalian TSC, results in increased lipid staining.  
This regulation functions in parallel to IIS through RSKS-1/S6K activation, and is thought to 
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have an effect on the expression of sbp-1 (Bar et al. 2016).  Conversely, TORC2 seems to inhibit 
lipid accumulation, as mutations in rict-1 result in animals with increased lipid staining.  This 
effect seems to occur through SGK-1 and exhibits only partial dependency on AKT-1/2 
activation in parallel to IIS (Jones et al. 2009; Soukas et al. 2009).  SGK-1 has been shown to 
inhibit the nuclear localization of the transcription factor PQM-1 to regulate intestinal lipid 
mobilization (Dowen et al. 2016). 
1.E. Thesis Rationale 
 The regulation of energy homeostasis is integral for the survival of organisms.  Both 
acquisition and utilization of nutrients are tightly controlled to provide energy for short-term and 
long-term survival.  In species from C. elegans to humans, regulation of homeostasis is 
maintained through a delicate balance of cellular signaling and biochemical activity (Table 1.1).  
Disruption at various points in this balance can result in metabolic disorders and diseases.  
Increasing evidence implicates a role for TGF-β/BMP signaling in regulating metabolic 
homeostasis, though how those signals are integrated into well-known networks, such as IIS and 
TOR, is less understood. 
  DBL-1 signaling is most well-known for its role in development and regulation of 
body size; however, previous data from our lab implicated DBL-1 in the regulation of various 
genes involved in lipid metabolism, β-oxidation, mitochondria, and peroxisomes, all of which 
play a role in metabolic homeostasis (Liang et al. 2007).  To further investigate the role of DBL-
1 signaling in energy metabolism, we characterize lipid accumulation in dbl-1 mutants.  Both 
down and up-regulation of DBL-1 result in reduced overall lipid stores, as visualized by Oil Red 
O staining.  Alterations in the size of lipid droplets is seen through both imaging of DHS-3::GFP, 
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a dehydrogenase localized to the membrane of lipid droplets, and electron micrographs.  
However, lipid droplet size responds to DBL-1 signaling in a dose-dependent manner.  Together, 
these data implicate DBL-1 signaling as an important factor in regulating lipid storage.  Through 
the use of tissue-specific expression of sma-3, we show that SMAD signaling is sufficient in the 
hypodermis to rescue the low-fat phenotype of sma-3 mutants.  This indicates that DBL-1 
signaling regulates lipid metabolism in a non-cell-autonomous manner, similar to what is seen in 
the regulation of body size (Wang et al. 2002).  We then examine the interaction of DBL-1 and 
DAF-2 signaling pathways.  Insulin-like ligands were found in the microarray that identified 
numerous metabolic genes (Liang et al. 2007), and DAF-2 is a well-characterized regulator of 
metabolic homeostasis.  By using genetic epistasis, we place DAF-2 downstream of DBL-1 
signaling in the regulation of overall lipid stores.   
To further explore the relationship between the two pathways we examine interactions in 
multiple phenotypes.  We show that DBL-1 and DAF-2 independently regulate body size.  daf-
2;sma-3 mutants have intermediate body size compared to either single mutant.  However, DBL-
1 antagonistically affects dauer formation, autophagy, and lifespan in a DAF-2-dependent 
manner, only exhibiting effects in a DAF-2 sensitized background.  daf-2;sma-3 mutants exhibit 
the formation of fewer dauers only at the semi-permissive temperature of 20°C, compared to daf-
2 mutants, while sma-3 mutants do not form dauers.  Autophagy is visualized through the use of 
GFP::LGG-1, a marker of autophagic activity.  Similar to the trend seen in dauer formation, daf-
2;dbl-1 mutants exhibit a reduction in GFP::LGG-1 puncta compared to daf-2 mutants, while 
dbl-1 mutants do not show a reduction in puncta.  Both phenotypes respond in a DBL-1 dose-
dependent manner.  Additionally, lifespan is similarly affected by the loss of SMA-3 in a daf-2 
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mutant background.  daf-2;sma-3 mutants exhibit a reduction in survival compared to daf-2 
mutants, while sma-3 mutants are not significantly different from the wild-type control. 
We propose INS-4 as a candidate for interaction between the two pathways.  ins-4 
expression was found to be decreased in both dbl-1 and sma-9 mutant backgrounds (Liang et al. 
2007), and is expressed in the hypodermis.  We show that expression of INS-4::GFP is up-
regulated in a sma-3 mutant background.  Additionally, we observe an increase in overall lipid 
accumulation in sma-3;ins-4 mutants that places INS-4 downstream of SMA-3.  These results 
implicate INS-4 as a candidate for direct signaling from DBL-1 to DAF-2.  In conjunction, we 
propose that components downstream of DBL-1 signaling affect the localization of DAF-16 and 
SKN-1 in a DAF-2-independent manner.  We observe that SKN-1 no longer properly responds to 
DAF-2 signaling in a dbl-1 mutant background.  In conclusion, this work identifies DBL-1 
signaling as a regulator of multiple homeostatic functions in co-ordination with DAF-2 signaling 
in C. elegans. 
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2.A. Abstract 
Metabolic homeostasis is coordinately controlled by diverse inputs. Understanding these 
regulatory networks is vital to combating metabolic disorders. The nematode Caenorhabditis 
elegans has emerged as a powerful, genetically tractable model system for the discovery of lipid 
regulatory mechanisms. Here we introduce DBL-1, the C. elegans homolog of bone 
morphogenetic protein 2/4 (BMP2/4), as a significant regulator of lipid homeostasis. We used 
neutral lipid staining and a lipid droplet marker to demonstrate that both increases and decreases 
in DBL-1/BMP signaling result in reduced lipid stores and lipid droplet count. We find that lipid 
droplet size, however, correlates positively with the level of DBL-1/BMP signaling. Regulation 
of lipid accumulation in the intestine occurs through non-cell-autonomous signaling, since 
expression of SMA-3, a Smad signal transducer, in the epidermis (hypodermis) is sufficient to 
rescue the loss of lipid accumulation. Finally, genetic evidence indicates that DBL-1/BMP 
functions upstream of Insulin/IGF-1 Signaling in lipid metabolism. We conclude that BMP 
signaling regulates lipid metabolism in C. elegans through interorgan signaling to the Insulin 
pathway, shedding light on a less well-studied regulatory mechanism for metabolic homeostasis. 
 
 
 
 
 
Keywords: BMP, Insulin, Lipid, Homeostasis, Caenorhabditis elegans 
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2.B. Introduction 
Metabolic homeostasis in animals relies on integrating input from numerous sources to 
coordinately regulate energy intake and expenditure across multiple organs. Nutrient sensing 
pathways relay signals in the absence or presence of food. Simultaneously, feedback loops are 
triggered in response to the lack or abundance of cellular resources.  Satiety responses are 
produced to slow the intake of energy when sufficient resources have been obtained. The balance 
of these pathways provides the basis of metabolic homeostasis. Metabolic disorders, such as type 
II diabetes, are the result of an imbalance in the signaling web that is homeostasis. The last few 
decades have provided numerous insights into this regulatory network, but new regulatory 
interactions continue to be discovered. 
The Transforming Growth Factor beta (TGFβ) superfamily is a major group of peptide ligands 
conserved across animal phyla. The superfamily includes the founding TGFβs, as well as Bone 
Morphogenetic Proteins (BMPs), growth and differentiation factors (GDFs), Activin, Nodal, and 
others. These peptides signal through conserved signal transduction pathways responsible for 
development, growth, and differentiation (Shi and Massague 2003; Wu and Hill 2009).  
Intriguingly, emerging evidence from correlative studies in humans, as well as in vivo studies in 
mice, implicate several TGFβ ligands in lipid metabolism and homeostasis (Wang et al. 2004; 
Fain et al. 2005; Sjoholm et al. 2006; Bottcher et al. 2009; Shen et al. 2009).   
BMPs are a group of TGFβ-related signals with key regulatory roles in development and 
differentiation. Mammalian BMP2 and BMP4 play important roles in early development and cell 
differentiation, as well as being critical for bone and cartilage development (Chen et al. 2004). In 
Drosophila, the BMP ligand DPP is required for dorsoventral patterning of the early embryo as 
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well as later patterning of the imaginal discs (Spencer et al. 1982; Padgett et al. 1987). However, 
the homeostatic roles of BMP ligands are less well studied. We have used molecular genetic and 
imaging tools available in the nematode C. elegans to gain insight into the homeostatic roles of 
BMP ligands.  
C. elegans has a conserved BMP signaling pathway that includes founding members of the Smad 
family of signal transducers, SMA-2, SMA-3, and SMA-4 (Savage et al. 1996).  DBL-1, the C. 
elegans BMP2/4 homolog, plays a major role in body size regulation, male-tail development, and 
mesodermal patterning (Suzuki et al. 1999; Foehr et al. 2006). Initial evidence of a role for DBL-
1 in metabolism came from our microarray analysis of genes regulated by the DBL-1 pathway. 
This analysis identified several genes related to fat metabolism including genes encoding fatty 
acid desaturases and genes involved in β-oxidation (Liang et al. 2007). C. elegans is a prominent 
model system for the study of lipid homeostasis, and is particularly suitable for the identification 
of cell and tissue interactions that mediate homeostasis (Ashrafi 2007). Although nematodes do 
not possess dedicated adipocytes, they store triglycerides in lipid droplets in the intestine and in 
epidermal tissue (the hypodermis) via biochemical mechanisms that are evolutionarily 
conserved. 
In this study, we show that DBL-1/BMP signaling plays an important role in regulating lipid 
stores in C. elegans. Alterations to DBL-1 signaling levels result in a loss of lipids and changes 
in lipid droplet morphology. DBL-1 signaling acts non-cell-autonomously in the hypodermis to 
regulate lipid storage in the intestine. Finally, we show that the lipid phenotype of dbl-1 mutants 
is reliant on Insulin/IGF-1 Signaling (IIS), a well-known regulator of fat metabolism (Kimura et 
al. 1997).   
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2.C. Materials and Methods 
Nematode strains and growth conditions 
C. elegans were maintained on E. coli (DA837) at 15°C, 20°C, and 25°C as specified.  The wild-
type strain used in this study was N2.  The strains used in this study are as follows: LT121 dbl-
1(wk70), CB678 lon-2(e678), CS24 sma-3(wk30), CS152 sma-3(wk30);qcIs6 [sma-
3p::gfp::sma-3+rol-6], CS619 sma-3(wk30);qcIs59 [vha-6p::gfp::sma-3+rol-6], CS628 
sma-3(wk30);qcIs55 [vha-7p::gfp::sma-3+rol-6], CS630 sma-3(wk30);qcIs53 
[myo-3p::gfp::sma-3+rol-6], BW1490 ctIs40 [dbl-1(OE)+sur-5::gfp], CB1370 daf-2(e1370), 
LIU1 ldrIs1  [dhs-3p::dhs-3::gfp+unc-76(+)], BX106 fat-6(tm331), BX153 fat-7(wa36), BX156 
fat-6(tm331);fat-7(wa36). Crosses were used to obtain: daf-2(e1370);lon-2(e678), 
daf-2(e1370);sma-3(wk30), dbl-1(wk70);ldrIs1, ctIs40;ldrIs1, daf-2(e1370);ldrIs1, 
daf-2(e1370);dbl-1(wk70);ldrIs1. 
Oil Red O Staining 
Protocol adapted from (O'Rourke et al. 2009).  Animals were collected at the L4 stage in PCR 
tube caps and washed three times in PBS.  Worms were then fixed for 1 hour in 60% isopropanol 
while rocking at room temperature.  The isopropanol was removed and worms were stained 
overnight with 60% Oil Red O solution while rocking at room temperature.  Oil Red O was 
removed and the worms were washed once with PBS w/ .01% Triton and left in PBS.  Worms 
were mounted and imaged using an AxioCam MRc camera with AxioVision software.  Images 
were taken using a 40X objective.  Oil Red O stock solution was made with 0.25g Oil Red O in 
50mL isopropanol.  Intensity of the post-pharyngeal intestine was determined using ImageJ 
software. Unless otherwise noted, three regions were measured (anterior, midbody, and 
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posterior) using equivalently sized windows. Pixel intensity was measured in the green color 
channel of the images.  Three measurements using a 50px by 50px area were taken at each 
region with background intensity subtracted for each individual picture.  Statistical comparisons 
(two-way ANOVA, one-way ANOVA with post-hoc Tukey’s multiple comparisons test, and 
unpaired t-test) were performed using GraphPad Prism 7 software.  For each experiment, n>20 
per strain repeated in triplicate. 
Body size 
Animals were collected at the L4 stage and anesthetized with sodium azide.  The worms were 
then imaged using a QImaging Retiga EXi camera with QCapture software.  The midline of each 
worm was then measured in ImagePro.  Statistical comparisons (one-way ANOVA with post-hoc 
Tukey’s multiple comparisons test, two-way ANOVA, and unpaired t-test) were performed using 
GraphPad Prism 7 software.  For each experiment, n>30 per strain repeated in triplicate. 
Electron Microscopy 
Animals were fixed and embedded by standard methods (Hall 1995).  Fixation and microscopy 
was performed by the David H Hall lab.  Animals were well-fed adults grown at 20°C.  Animals 
were fixed 2 days post-egg laying. N2 n=4, dbl-1 n=2, sma-3 n=5, sma-9 n=3. 
Lipid Droplet Morphology 
Animals were collected at the L4 stage and anesthetized with sodium azide.  The worms were 
then imaged using a Zeiss ApoTome with AxioVision software.  Images were taken using a 
100X objective.  The tail region of the worm was imaged and the diameter and count of all 
visible lipid droplets in a 400µm2 area were measured using AxioVision software.  Statistical 
comparisons (one-way ANOVA with post-hoc Tukey’s multiple comparisons test, two-way 
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ANOVA with post-hoc Holm-Sidak’s multiple comparisons test, and unpaired t test with 
Welch’s correction) were performed using GraphPad Prism 7 software.  For each experiment, 
n>15 per strain repeated in triplicate. 
Pharyngeal Pumping Rate 
Pumping rate was counted by the number of contractions of the pharyngeal bulb per 20 seconds.  
Two counts were made per worm and averaged.  n>10 per strain repeated in triplicate. Statistical 
comparisons (unpaired t test with Welch’s correction) were performed using GraphPad Prism 7 
software.   
2.D. Results 
     2.D.i. DBL-1/BMP Signaling is Required for Lipid Accumulation 
Our previous data identified numerous lipid metabolism genes as downstream targets of DBL-
1/BMP signaling via microarray analysis (Liang et al. 2007).  These genes include fat-6 and 
fat-7, which encode Δ9 fatty acid desaturases homologous to stearoyl coA desaturase (SCD). 
Mutations in either gene result in an overall decrease in neutral lipids, in addition to other 
phenotypes (Watts and Browse 2002; Ntambi et al. 2004). To determine if DBL-1 signaling is 
important for lipid metabolism, we measured stored lipid levels in animals with altered DBL-1 
function as well as those with mutations in fat-6, fat-7, or both. Animals were grown at the 
standard temperature of 20°C and stained with Oil Red O, at the fourth larval stage (L4), to 
quantify overall neutral lipid content, including lipid storage in the intestine and in the 
hypodermis. Consistent with previous reports, we observed a significant decrease in Oil Red O 
staining in fat-6, fat-7, and fat-6;fat-7 mutant animals by ~45% compared to wild type. Similarly, 
we observed a decrease in dbl-1 mutants by ~35% compared to wild type. This decrease was not 
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significantly different from that observed in the fat mutants (p>0.38). We also analyzed a loss of 
function mutation in lon-2, which encodes a negative regulator of DBL-1 signaling (Gumienny et 
al. 2007). Interestingly, lon-2 mutants also had a reduction in staining, at levels similar to that of 
dbl-1 mutants (p=.99) (Figure 2.1A, B). A possible cause for the decrease in lipid storage is a 
reduction in food uptake, as seen in eat-2 mutants (Raizen et al. 1995). However, dbl-1 mutants 
had a very slight increase in the rate of pharyngeal contractions, while sma-3 animals had no 
significant change from wild type (Figure 2.S1), and thus a decrease in food uptake is not likely 
to explain the decrease in lipid storage in dbl-1 or sma-3 mutants. 
     2.D.ii. Hypodermal Expression of Smads is Required for Lipid Accumulation 
This lipid storage phenotype led us to question in which tissues DBL-1 signaling is necessary to 
regulate fat metabolism. C. elegans do not have dedicated adipocytes, so fat is stored in the 
intestine and in the hypodermis. DBL-1 signaling components (receptors and Smads) are 
expressed in the pharynx, hypodermis, and intestine. We have previously shown that expression 
of sma-3/Smad in the hypodermis is sufficient and necessary to rescue the small body size 
phenotype of sma-3 mutants (Wang et al. 2002).  We took the same approach of directing 
expression of sma-3(+) to specific tissues, in an otherwise sma-3 mutant background and 
measured fat accumulation using Oil Red O.  
Surprisingly, our results showed that sma-3 expression in the hypodermis is also sufficient for 
rescue of the low-fat phenotype in sma-3 mutants (Figure 2.1C, D). Although sma-3 expression 
in the pharynx resulted in a slight increase in Oil Red O staining, intestinal sma-3 expression in 
sma-3 mutants resulted in a further decrease in staining, compared to sma-3 mutant animals.   
Thus, expression in either pharyngeal tissue or intestine was not sufficient to rescue the lipid 
stores in sma-3 mutants to wild-type levels.  However, when sma-3 was expressed in either the 
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hypodermis or all three tissues, Oil Red O intensity was rescued to wild-type levels with no 
significant difference observed (p>0.78) (Figure 2.1C, D). These data indicate that Smad activity 
functions non-autonomously in the hypodermis to regulate fat storage in the intestine.   
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Figure 2.1.  Functions and Tissue-Specificity of DBL-1 Signaling in Lipid Storage. A) Both 
dbl-1 and lon-2 mutants show a decrease in lipid levels via Oil Red O staining, similar to that of 
fat mutants.  Animals were grown at 20°C and stained at the L4 larval stage. Quantification was 
done for equivalent regions of the intestine just posterior to the pharynx.  B) Images of L4 
animals stained with Oil Red O taken at 400X.  C) Loss of sma-3 results in decreased lipid 
levels.  Expression of sma-3 in the hypodermis is sufficient to rescue the lipid phenotype.  
Expression in either the pharynx or the intestine cannot rescue lipids to wild-type levels.  
Animals were grown at 20°C and stained at the L4 larval stage. Quantification was done for 
equivalent regions of the intestine just posterior to the pharynx.  D) Images of L4 animals stained 
with Oil Red O taken at 400X.  Anterior is to the left. For all graphs, asterisks across the bottom 
denote significance compared to Control, n.s. not significant, *** p value < .001, error bars 
denote SEM. 
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     2.D.iii. DBL-1/BMP Functions Upstream of IIS to Regulate Lipid Accumulation 
Our tissue specific rescue experiments suggest that SMA-3/Smad activity in the hypodermis may 
regulate the expression of a secreted ligand that signals to the intestine. One potential mechanism 
by which this signaling may occur is through the regulation of insulin ligands. C. elegans uses 
multiple insulin-like ligands that act through a single insulin receptor, DAF-2/InsR (Pierce et al. 
2001). The IIS pathway in C. elegans was first identified for its role in regulating dauer 
development. A temperature sensitive mutation in daf-2, when exposed to the restrictive 
temperature of 25°C, results in the development of daf-2/InsR mutants into dauers, an alternate 
L3 stage utilized for survival in high stress environments. In addition, daf-2 mutants exhibit other 
phenotypes, including increased lifespan and stress tolerance (Gottlieb and Ruvkun 1994; 
Tissenbaum and Ruvkun 1998). Moreover, the involvement of Insulin/IGF-1 Signaling (IIS) in 
fat metabolism is well documented in C. elegans (Kimura et al. 1997). Notably, our microarray 
analysis revealed ins-4 as a transcriptional target of the DBL-1 pathway; expression was 
increased in both dbl-1 and sma-9 mutant backgrounds. INS-4 is an insulin-like ligand expressed 
in the hypodermis, in addition to neurons (Ritter et al. 2013). 
We therefore constructed strains containing mutations in both BMP and IIS pathways to test 
interactions between these pathways via genetic epistasis. To bypass dauer arrest in daf-2 mutant 
animals, these experiments were conducted by raising animals at the permissive temperature of 
15°C followed by a shift to 25°C. Our findings confirmed the high fat phenotype of daf-2 
mutants, exhibiting an average increase of 18% over wild type. Similarly, daf-2;sma-3 double 
mutants showed an average increase in Oil Red O intensity of 11% (Figure 2.2A), which is not 
significantly different from daf-2 (p=0.71). We concluded that the daf-2 high-fat phenotype is 
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epistatic to the dbl-1 low-fat phenotype, suggesting that daf-2 acts downstream of dbl-1 with 
regard to fat storage regulation. 
We also assessed mutants in other components of the DBL-1 pathway. sma-3 mutants had an 
average reduction in Oil Red O intensity of more than 50%. To examine increased DBL-1 
activity, we used both a dbl-1 overexpression strain and lon-2 mutants, which are deficient in a 
negative regulator of DBL-1. Consistent with the observation from lon-2 mutants, a dbl-1 
overexpression strain [dbl-1(OE)] also exhibited a reduction in lipid stores (~25% less) (Figure 
2.2A, C). This finding indicates precise regulation of DBL-1 signaling is required to maintain 
wild-type levels of lipids. It also indicates that the lipid and body size phenotypes of the DBL-1 
pathway are independent, as both long and short animals exhibited decreased lipids. daf-2;lon-2 
double mutants, like daf-2;dbl-1 mutants, have an increase in fat accumulation indistinguishable 
from that of daf-2 single mutants (p>0.71). This epistatic relationship between the two pathways 
suggests that IIS functions downstream of DBL-1 signaling in the regulation of fat accumulation. 
     2.D.iv. DBL-1/BMP and IIS Pathways Independently Contribute to Body Size 
We also tested whether these two pathways interact to regulate body size. Small body size was 
the first identified phenotype of the DBL-1 pathway (Savage et al. 1996; Suzuki et al. 1999). We 
measured animals at the L4 stage, benchmarked against wild-type controls: dbl-1 mutant animals 
showed an average body length reduction of 25%; sma-3 body length was reduced by 19%. 
Conversely, an increase in DBL-1 signaling resulted in an increase in body size, as lon-2 mutants 
exhibited an average increase of 26%.  Interestingly, a downregulation of DAF-2/InsR showed a 
significant increase in body size by an average of 32% compared to wild type. When animals 
with mutations in both pathways were measured, an additive effect was observed. The daf-2;lon-
2 mutant animals had an average increase in length of 48.0% compared to wild type, while the 
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daf-2;sma-3 mutant animals were comparable to the length of wild type (Figure 2.2B, C).  These 
data are consistent with an independent study by the Baumeister lab (Qi et al. 2017) and suggests 
that the DBL-1 and IIS pathways work independently to regulate the overall body size of C. 
elegans. 
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Figure 2.2. DBL-1 Signaling Functions Upstream of IIS to Regulate Lipid Storage but not 
Body Size. A) daf-2;lon-2 and daf-2;dbl-1 display the high fat phenotype of daf-2 animals using 
Oil Red O. Graphs show combined data from three equivalent regions of each worm. See 
Supplementary Figure S2 for separated data from each region. Epistasis analysis places DBL-1 
signaling upstream of daf-2/InsR.  dbl-1(OE) animals show a similar decrease in lipid levels as 
dbl-1 and lon-2 mutants.  Animals were grown at 15°C until the L2/L3 molt and then shifted to 
25°C and stained at the L4 larval stage.  The center line denotes mean and the error bars denote 
SD.  B) Animals containing mutations in both DBL-1 pathway components and daf-2 exhibit 
additive body sizes.  Both pathways regulate body size independently.  Animals were grown at 
15°C until the L2/L3 molt and then shifted to 25°C and measured at the L4 larval stage.  Boxes 
denote the 2nd and 3rd quartiles, whiskers denote min and max values.  C) Images of L4 animals 
stained with Oil Red O taken at 200X.  Anterior is to the left. For all graphs, asterisks across the 
bottom denote significance compared to Control, n.s. not significant, * p value < .05, *** p value 
< .001. 
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     2.D.v. Changes to DBL-1/BMP Signaling Levels Alter Lipid Droplet Morphology 
To determine how the DBL-1 pathway regulates lipid stores at a subcellular level, we analyzed 
lipid droplet morphology. Lipid droplets are vital for the utilization and storage of energy at the 
cellular level and are highly regulated. The morphology of lipid droplets can be an indicator of 
the function and well-being of a cell, or an organism. In humans, the function of white adipose 
tissue and brown adipose tissue differ significantly; these differences primarily reflect how they 
regulate lipid droplets (Meex et al. 2009; Yu et al. 2015; Luo and Liu 2016). We first examined 
lipid droplet morphology via electron microscopy. Images of dbl-1, sma-3, and sma-9 mutants 
depict worms with much smaller lipid droplets in the intestine, compared to that of wild-type 
animals (Figure 2.3).   
To visualize lipid droplets in a larger sample size, we used transgenic animals expressing DHS-
3::GFP (Figure 2.4). DHS-3 is a short-chain dehydrogenase shown to bind to the surface of lipid 
droplets (Zhang et al. 2010b). DHS-3::GFP is expressed specifically in the intestine and not in 
the hypodermis. Animals were grown and analyzed at the standard growth temperature of 20°C. 
We measured the diameters of lipid droplets labeled with DHS-3::GFP. Our data indicate that 
lipid droplet size is positively correlated with DBL-1 signaling levels. Wild-type animals with 
DHS-3::GFP have an average lipid droplet diameter of 1.02 μm, with a maximum diameter of 
2.26 μm (Figure 2.4A, C). The dbl-1 mutants show a decrease in average droplet diameter to 
0.58 μm (p<0.001), with a maximum diameter of only 1.06 µm, a decrease of about 53%. This 
reduction in lipid droplet size is consistent with the reduced lipid droplet size seen by EM. The 
overexpression strain, on the other hand, shows an increase to 1.13 μm on average (p<0.001), 
with a maximum diameter of 2.54 µm, an increase of over 12%. The dbl-1 mutants displayed the 
lowest level of variance indicating that a decrease in dbl-1 expression confines the size of lipid 
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droplets to a smaller range compared to wild type. The dbl-1(OE) mutants displayed a slightly 
larger level of variance compared to wild type, which indicates an increase in the maximum size 
of lipid droplets, but does not restrict the minimum size compared to wild type.   
We next determined the density of lipid droplets per unit area by counting the total number of 
lipid droplets per 400 μm2. Wild-type animals had an average of 40 droplets, while both dbl-1 
and dbl-1(OE) showed a decrease, 24 (p<0.001) and 27 (p<0.001) per unit area, respectively 
(Figure 2.4B, C). The decreased numbers of lipid droplets are concordant with the decreased 
intensity of Oil Red O staining in both loss-of-function and gain-of-function backgrounds. The 
dbl-1(OE) mutants displayed a lower level of variance compared to the wild-type and dbl-1 
strains, which may help account for their overall decrease in lipids observed via Oil Red O 
staining (Figure 2.2A). Thus, while both decreasing and increasing DBL-1 signaling resulted in a 
reduction in total fat accumulation, the mechanisms at the level of lipid droplet size are different.  
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Figure 2.3.  DBL-1 Pathway Mutants Exhibit a Decrease in Lipid Droplet Size via Electron 
Microscopy.  dbl-1, sma-3, and sma-9 mutants mid-body sections display smaller lipid droplets 
compared to those seen in wild type.  Black arrowheads depict representative lipid droplets, 
white arrowhead depicts lysosome-like organelle, yellow arrow depict possible yolk droplets..  L 
marks the intestinal lumen, which tends to be enlarged and filled with bacteria in DBL-1 
pathway mutants. Animals were grown at 20°C and imaged at adulthood 2 days post egg lay. 
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Figure 2.4. DBL-1 Pathway Regulates Lipid Droplet Morphology. A) Lack of dbl-1 results in 
significantly smaller lipid droplets, while overexpression of dbl-1 increases the average diameter 
of lipid droplets.  dhs-3::gfp was used to visualize lipid droplets.  Animals were grown at 20°C 
and imaged at the L4 larval stage. B)  Both a loss or an increase in DBL-1 signaling results in a 
reduction in the overall number of lipid droplets in the animals.  dhs-3::gfp was used to visualize 
lipid droplets.  Animals were grown at 20°C and imaged at the L4 larval stage.  C) Images of L4 
animals with altered levels of DBL-1.  Images depict the posterior end of the intestine taken at 
1000X.  For all graphs, n.s. not significant, *** p value < .001, boxes denote 2nd and 3rd 
quartiles, whiskers denote min and max values. 
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     2.D.vi. DBL-1/BMP Regulation of Lipid Droplet Morphology is Partially Dependent on 
IIS 
Next, we wanted to determine if IIS is required for the lipid droplet phenotypes of DBL-1 
signaling mutants. To bypass dauer arrest in daf-2 mutant animals, these experiments were 
conducted by raising animals at the permissive temperature of 15°C followed by a shift to 25°C. 
In the daf-2 mutant background, the average diameter of lipid droplets was 1.12 μm with a 
maximum diameter of 2.63 μm. This was significantly larger than those of wild type with an 
average of 0.90 μm and a maximum diameter of 2.37 μm (p<0.001) (Figure 2.5A, C). The daf-2 
mutants also had the greatest level of variance, indicative of having a greater range of diameters 
than any of the other strains. The daf-2;dbl-1 double mutants had an average diameter of 0.97 
μm and a maximum diameter of 2.34 μm. This size was similar to that of daf-2 mutants, but still 
smaller than in daf-2 mutants (p<0.001). Thus, for lipid droplet size, we do not observe the strict 
epistatic relationship seen in the Oil Red O experiments. These data suggest that the interaction 
between IIS and DBL-1 signaling may be slightly more complex and nonlinear at the lipid 
droplet level, with the possibility of a DAF-2-independent function for DBL-1. Alternatively, the 
deviation from epistasis may be due to our use of daf-2(e1370), a strong loss-of-function but not 
a null allele, which would be inviable. 
Next, we examined the average number of lipid droplets in the animals. daf-2 exhibited a 
significant increase compared to wild type, 55 and 34 (p<0.001), respectively. The daf-2;dbl-1 
animals were similarly increased over wild type, at 46 droplets (p=0.039).  The increased count 
of daf-2 and daf-2;dbl-1 were similar to each other and not significantly different (p=0.276). 
Interestingly, the dbl-1 mutant did not exhibit a significant decrease in lipid droplet count 
compared to wild type, 27 versus 34 (p=0.471); the variance between the two samples was also 
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very similar, suggesting no change between the two strains. These data suggest that DBL-1 
regulation of lipid droplet count may be temperature sensitive (Figure 2.5B, C). 
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Figure 2.5.  DBL-1 Regulates Lipid Droplet Size in part via IIS. A) The average diameter of 
lipid droplets in daf-2;dbl-1 mutants is similar to but slightly distinct from that of daf-2 single 
mutants, suggesting a partially independent effect from the DBL-1 pathway.  dhs-3::gfp was 
used to visualize lipid droplets.  Animals were grown at 15°C until the L2/L3 molt and then 
shifted to 25°C and imaged at the L4 larval stage.  B)  daf-2 mutants exhibit an increase in lipid 
droplet count compared to both wild type and dbl-1.  At 25°C, dbl-1 does not have a significant 
effect on the number of lipid droplets.  dhs-3::gfp was used to visualize lipid droplets.  Animals 
were grown at 15°C until the L2/L3 molt and then shifted to 25°C and imaged at the L4 larval 
stage.  C) Images of L4 animals containing mutations in either daf-2, dbl-1, or both.  Images 
depict the posterior end of the intestine taken at 1000X.  For all graphs, n.s. not significant, * p 
value < .05, *** p value < .001, boxes denote 2nd and 3rd quartiles, whiskers denote min and max 
values. 
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2.E. Discussion 
In this study, we present evidence that DBL-1/BMP signaling plays an important role in lipid 
metabolism, as DBL-1 pathway mutants, as well as dbl-1 overexpression, have a distinct 
decrease in lipid stores via Oil Red O staining. A similar conclusion was reached independently 
by Yu et. al 2017. In addition, we show that lipid droplet morphology of DBL-1 pathway 
mutants is significantly changed from wild type. We have identified a non-autonomous 
mechanism for this regulation, since DBL-1 signaling activity in the hypodermis is sufficient to 
maintain proper lipid levels in the intestine. The epistasis of daf-2/InsR in daf-2;dbl-1 double 
mutants indicate that DBL-1 regulates lipid levels by modulation of DAF-2/InsR activity. These 
data implicate a BMP - IIS signaling axis as a major player in the regulation of lipid metabolism. 
Our model is illustrated in Figure 6. DBL-1 is expressed primarily in neurons, from which it 
signals to the Smad pathway in the hypodermis, leading to inhibition of the IIS pathway and 
stimulation of lipid storage. Observed differences in the lipid droplet morphology between daf-
2;dbl-1 double mutants and daf-2 single mutants suggest that there may also be DAF-2-
independent regulation of lipids by DBL-1 (arrow with question mark). 
We find that the lipid and body size phenotypes of DBL-1 are separable. Additionally, DAF-
2/InsR regulates body size independently of DBL-1. Interestingly, the effect of daf-2 on body 
size is opposite of that seen in many other species. In Drosophila, mutations in InR/InsR and 
chico/IRS display reduced body size resulting from decreased cell number and size (Bohni et al. 
1999). In spite of this, the direction of the lipid-related phenotypes of IIS in Drosophila and in C. 
elegans is the same (Bohni et al. 1999). In mice, as in Drosophila, deficiency in IGF-I or IGF-II 
causes stunted growth and significant decreases in body weight (Baker et al. 1993). The reason 
for the shift in growth-regulating function of IIS in C. elegans is unknown. 
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Our findings are part of an emerging body of evidence for interactions between BMP and IIS 
pathways. In C. elegans, DBL-1 and IIS promote germline proliferation (Qi et al. 2017).  The 
Baumeister lab has shown that the IIS transcription factor DAF-16/FOXO and SMA-3/Smad 
interact in the hypodermis to regulate this germline function. The DBL-1 and IIS pathways have 
been also shown to regulate reproductive aging, but in this case they act independently (Luo et 
al. 2009; Luo et al. 2010), similar to their independent functions in body size regulation. In this 
study, we report the first evidence of interaction between the DBL-1 and IIS pathways that 
produce an effect in a somatic tissue, the intestine. It is also possible that similar interactions 
occur in vertebrates, since BMP signaling can influence insulin sensitivity in mice (Schulz et al. 
2016; Chattopadhyay et al. 2017). 
Lipid droplets are vital for the utilization and storage of energy at the cellular level and are 
highly regulated. Lipid droplet size is maintained by the balance of triglyceride production and 
β-oxidation.  When peroxisomal β-oxidation is inhibited, such as in maoc-1, dhs-28, and daf-22 
mutants in C. elegans, average lipid droplet size is increased significantly over wild type (Zhang 
et al. 2010b). Conversely, when fatty acid synthesis is inhibited, lipid droplet size is decreased. 
Animals containing mutations in fat-6 and fat-7, genes responsible for the first desaturation step 
in creating polyunsaturated fatty acids, display a significant decrease in average lipid droplet size 
(Shi et al. 2013). Multiple nutrient sensing pathways exist to provide regulatory signals that 
dictate lipid droplet mobilization. Lipid droplet morphology can be closely linked to the input of 
these pathways as energy demands fluctuate with available food. The lipid droplet size 
phenotype of fat-6;fat-7 mutants was shown to be independent of the AMPK and TOR pathways. 
However, it was shown that fat-6 and fat-7 work in conjunction with IIS, as both are required for 
the large lipid droplet size phenotype of daf-2/InsR mutants (Shi et al. 2013).   
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Our data have introduced DBL-1 signaling as a key factor in maintaining proper lipid droplet 
homeostasis through IIS. Future work will examine whether DBL-1 signaling influences IIS 
through the transcriptional regulation of insulin-like ligand genes. As SMA-3 functions in the 
hypodermis, but not the intestine, it may be that DBL-1 signaling is limiting the production of 
insulin-like ligands in the hypodermis, reducing the level of DAF-2 signaling in the intestine 
(Figure 2.6). We will also examine whether Smads interact with transcription factors 
downstream of DAF-2/InsR, such as DAF-16/FoxO and SKN-1/Nrf, to regulate lipid 
metabolism. Finally, the question of how an overexpression of DBL-1 leads to an overall 
reduction in lipids, while increasing the average diameter of lipid droplets, remains. Addressing 
these questions promises to yield further insight into whole-body lipid homeostasis by these 
conserved signaling pathways. 
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Figure 2.6. Non-Cell-Autonomous Interaction of DBL-1 and IIS to Regulate Lipids. Our 
data suggest that Smad activation in the hypodermis is sufficient to maintain proper lipid stores.  
This effect may occur through controlled expression of insulin-like ligands, which in turn 
regulate the DAF-2/IIS response in the intestine. 
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2.G. Supplemental Figures 
 
Figure 2.S1. Pharyngeal Pumping Rate in DBL-1 Pathway Mutants. The pharyngeal 
pumping rate dbl-1 is slightly higher than that of wild type, increased on average by only 1 extra 
pump every 20 seconds.  sma-3 animals showed no significant change in pumping rate compared 
to wild type.  DBL-1 pathway mutants appear to eat at the same rate, therefore their lack of lipid 
stores is not a result of nutrient deprivation.  Animals were grown at 20°C. * p value < .05, error 
bars denote SEM. 
  
C. ELEGANS DBL-1 REGULATES LIPID ACCUMULATION VIA IIS 
58 
 
 
Figure 2.S2. Oil Red O Staining in Different Anatomical Regions. Staining intensity was 
measured at the anterior intestine, midbody, and posterior intestine. In each anatomical region, 
strains examined showed the same trend in lipid content. Animals were grown at 15°C until the 
L2/L3 molt and then shifted to 25°C and stained at the L4 larval stage.  Error bars denote SEM.   
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Contribution:   Construction of strains containing adIs2122 in daf-2;dbl-1, daf-2;lon-2, dbl-1 and 
lon-2 mutant backgrounds, as well as all imaging and quantification of gfp::lgg-1 autophagy was 
performed by GR.  Lifespan assay was performed by SA.  Dauer formation assay, Oil Red O 
staining, and imaging of ins-4::gfp¸skn-1::gfp, and daf-16::gfp containing strains was performed 
by myself.  Crosses to obtain dbl-1;ldIs7 and dbl-1;zIs356 strains was performed by myself.  All 
data analysis, statistical interpretation, and figure generation was performed by myself through 
the use of GraphPad Prism and Adobe Photoshop.  Manuscript writing and preparation were 
performed by me and my advisor, CSD. 
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3.A. Abstract 
Previously we identified DBL-1, the C. elegans ortholog of bone morphogenetic protein 2/4 
(BMP2/4), as a regulator of lipid homeostasis acting through DAF-2/Insulin/IGF1-like signaling 
(IIS).  Here we further explore that interaction by observing the effects of DBL-1/BMP signaling 
on multiple phenotypes associated with DAF-2/IIS.  We found that DBL-1/BMP signaling acts 
in a dose-dependent manner antagonistically to DAF-2/IIS to regulate dauer induction, longevity, 
and autophagy, but only in a daf-2-deficient genetic background. daf-2;sma-3 animals exhibited 
reduced dauer induction and longevity, daf-2;dbl-1animals exhibited reduced rates of autophagy, 
and daf-2;lon-2 animals exhibited increased dauer induction and autophagy, all compared to daf-
2 mutants, as mutations only in DBL-1/BMP signaling did not exhibit significant effects on the 
observed phenotypes.  Coupled with our previous work, we outline three modes of interaction 
between DBL-1/BMP and DAF-2/IIS: independent, epistatic, and antagonistic.  We found that 
the epistatic interaction can be attributed to the regulation of ins-4 by SMAD signaling; loss of 
sma-3 resulted in increased expression of ins-4p::GFP in the hypodermis, and sma-3;ins-4 
mutants exhibited a high-fat phenotype epistatic to the sma-3 low-fat phenotype.  To explain the 
antagonistic effects, we found that subcellular localization of SKN-1::GFP is altered in dbl-1 
mutants; additionally, SKN-1::GFP does not respond to the loss of daf-2, through RNAi, in a 
dbl-1 mutant background.  We conclude that DBL-1/BMP is able to contribute to the localization 
of transcription factors downstream of DAF-2/IIS and thus antagonistically affect the outputs of 
DAF-2/IIS. 
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3.B. Introduction 
The Transforming Growth Factor beta (TGFβ) superfamily is a major group of peptide ligands 
conserved across animal phyla, whose action is traditionally known for its roles in development, 
growth, and differentiation (Shi and Massague 2003; Wu and Hill 2009).  Bone morphogenetic 
proteins (BMPs) are TGFβ-related signals with key regulatory roles in development and 
differentiation. However, our research has explored the homeostatic effects of BMP signaling in 
the model organism C. elegans, using its powerful genetic tractability and imaging tools to 
elucidate key interactions between signaling pathways. In addition to our work, recently 
identified roles for TGFβ family members have been elucidated in regulating metabolic 
homeostasis in vertebrates (Wang et al. 2004; Fain et al. 2005; Sjoholm et al. 2006; Bottcher et 
al. 2009; Shen et al. 2009); BMPs in particular may play a role in insulin regulation and age-
related insulin resistance (Chattopadhyay et al. 2017). 
C. elegans has a conserved BMP signaling pathway that includes founding members of the Smad 
family of signal transducers, SMA-2, SMA-3, and SMA-4 (Savage et al. 1996).  DBL-1, the C. 
elegans BMP2/4 homolog, plays a major role in body size regulation, male tail development, and 
mesodermal patterning (Suzuki et al. 1999; Foehr et al. 2006). Initial identification of several 
genes related to fat metabolism through microarray analysis in both a dbl-1 and sma-9 mutant 
background (Liang et al. 2007) led to the hypothesis that DBL-1/BMP is a regulator of 
metabolism. Recently, we published that DBL-1/BMP signaling plays an integral role in lipid 
homeostasis, as disruptions to DBL-1 signaling lead to reduced intestinal lipid stores and altered 
lipid droplet morphology.  Additionally, we observed that this regulation was occurring through 
Insulin/IGF-1 signaling (IIS), as epistasis analysis placed DAF-2/Insulin Receptor downstream 
of SMAD signaling (Clark et al. 2018).   
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Metabolic homeostasis in all animals relies on the integration of multiple regulatory networks 
allowing an organism to assess both extrinsic and intrinsic cues. The combined inputs need to 
coordinately regulate energy mobilization across multiple tissues. Playing a central role in this 
regulatory web is IIS. Disruptions to insulin balance, such as insulin resistance, can lead to 
multiple metabolic disorders and diseases, such as obesity and type II diabetes. In C. elegans, the 
IIS pathway in utilizes the receptor DAF-2/InsR (Gottlieb and Ruvkun 1994; Kimura et al. 1997) 
in conjunction with over 40 predicted insulin-like peptides (ILPs) to regulate multiple 
homeostatic functions through the control of transcription factors, such as DAF-16/FOXO (Ogg 
et al. 1997; Paradis and Ruvkun 1998; Lin et al. 2001) and SKN-1/Nrf (Tullet et al. 2008).  DAF-
2/IIS has a prolific effect on the development and homeostasis of the worm; disruptions to DAF-
2/IIS lead to phenotypes in dauer formation, longevity, stress tolerance, innate immunity, 
germline maintenance, metabolism, and autophagy (Gems et al. 1998; Tissenbaum and Ruvkun 
1998; Jia et al. 2004; Brys et al. 2010; Kaplan and Baugh 2016).   
In this study, we show that DBL-1/BMP signaling not only regulates lipid metabolism, but a 
variety of homeostatic functions in conjunction with DAF-2/IIS.  We observe an antagonistic 
effect between DBL-1/BMP and DAF-2/IIS on dauer induction, autophagy, and longevity in a 
daf-2 mutant background.  Together with our previously published data on lipid stores and body 
size (Clark et al. 2018), our results outline three potential modes of interaction between DBL-
1/BMP and DAF-2/IIS: independent, as in body size; epistatic; as in lipid regulation; and 
antagonistic, as seen in dauer formation, autophagy, and longevity.  We observe that SMAD 
signaling in the hypodermis regulates expression of ins-4, and that ins-4 mutants express a high-
fat phenotype epistatic to that of sma-3, implicating INS-4 as the mediator for epistatic 
interaction.  Additionally, we observed a marked change in the sub-cellular localization of SKN-
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1::GFP in a dbl-1 mutant background, potentially providing a mechanism for the antagonistic 
effect observed in daf-2 mutant phenotypes.  Taken together, our data identify new methods of 
interaction to mesh the signaling outputs of two well-conserved pathways, DBL-1/BMP and 
DAF-2/IIS, in the regulation of homeostatic functions.   
3.C. Materials and Methods 
Nematode strains and growth conditions 
C. elegans were maintained on E. coli (DA837) at 15°C, 20°C, and 25°C as specified.  The wild-
type strain used in this study was N2.  The strains used in this study are as follows: LT121 dbl-
1(wk70), CB678 lon-2(e678), CS24 sma-3(wk30), CB1370 daf-2(e1370), RB2544 ins-
4(ok3534), HT1693 unc-119(ed3);wwEx63, DA2123 adIs2122, MAH14 daf-2(e1370);adIs2122, 
TJ356 zIs356, LD1 ldIs7, daf-2(e1370);sma-3(wk30), daf-2(e1370);lon-2(e678), . Crosses were 
used to obtain: CS663 sma-3(wk30);ins-4(ok3534), CS633 sma-3(wk30);wwEx63, CS661 daf-
2(e1370);dbl-1(wk70);adIs2122, daf-2(e1370);lon-2(e678);adIs2122, CS626 dbl-
1(wk70);adIs2122, CS627 lon-2(e678);adIs2122, dbl-1(wk70);zIs356, and dbl-1(wk70);ldIs7. 
Dauer formation assay 
Five to ten L4 animals were placed per plate to lay eggs overnight at 15°C.  Adults and L1s were 
removed on the subsequent day with M9.  Plates with remaining eggs were then placed at either 
20°C or 25°C to develop.  Animals were then observed 48 hours later; dauer larvae were tallied 
versus non-dauer larvae.  Statistical comparisons (unpaired t test and two-way ANOVA) were 
performed using GraphPad Prism 7 software.  n>50 per strain at each temperature, repeated in 
triplicate. 
GFP::LGG-1 autophagy assay 
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Autophagy was assayed via the formation of GFP punctae as described in (Palmisano and 
Meléndez 2016).  Animals were grown at 20°C and imaged at the L3 larval stage; dauer larvae 
were not imaged or quantified.  GFP::LGG-1 punctae were counted in the seam cells of the 
hypodermis.  Images were taken using a Zeiss ApoTome with AxioVision software and a 100X 
objective.  Exposure times were kept consistent across strains within each experiment.  Statistical 
comparisons (unpaired t test and one-way ANOVA) were performed using GraphPad Prism 7 
software.  n=15 per strain, repeated in duplicate. 
Lifespan assay 
Animals were initially grown at 15°C until reaching the L4 larval stage.  For each strain, 120 L4 
animals were plated onto 100mm petri dishes, 20 worms per plate.  Plates were then maintained 
at 25°C for the duration of the experiment.  Animals were transferred to new plates every other 
day.  Animals killed, missing, or exhibiting the bag of worms phenotype were censored from the 
final death count.  Kaplan-Meier survival curves and Mantel-Cox log-rank statistics were 
performed using GraphPad Prism 7 software. 
INS-4p::GFP Expression 
Animals were grown at 20°C and imaged as day 1 adults.  Images were taken on a Leica 
Microsystems Confocal microscope using a 20X objective.  Camera settings were maintained 
identically between all samples and trials.  Compound images were produced from compiling Z-
stack images. n>10 per strain repeated in triplicate. 
Oil Red O staining 
Protocol adapted from (O'Rourke et al. 2009).  Animals were collected at the L4 stage in PCR 
tube caps and washed three times in PBS.  Worms were then fixed for 1 hour in 60% isopropanol 
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while rocking at room temperature.  The isopropanol was removed and worms were stained 
overnight with 60% Oil Red O solution while rocking at room temperature.  Oil Red O was 
removed and the worms were washed once with PBS w/ .01% Triton and left in PBS.  Worms 
were mounted and imaged using an AxioCam MRc camera with AxioVision software.  Images 
were taken using a 40X objective.  Oil Red O stock solution was made with 0.25g Oil Red O in 
50mL isopropanol.  Intensity of the post-pharyngeal intestine was determined using ImageJ 
software. Pixel intensity was measured in the green color channel of the images.  Three 
measurements using a 50px by 50px area were taken for each worm with background intensity 
subtracted for each individual picture.  Statistical comparisons (two-way ANOVA, one-way 
ANOVA with post-hoc Tukey’s multiple comparisons test, and unpaired t-test) were performed 
using GraphPad Prism 7 software.  For each experiment, n>20 per strain repeated in triplicate. 
SKN-1::GFP Localization Assay 
RNAi induction and feeding were carried out as described in (Kamath et al. 2000).  L4 animals 
were placed on EZ worm plates supplemented with 1mM IPTG and 50mg/ml carbenicillin 
seeded with HT115 E. coli.  Animals were allowed to lay eggs overnight.  Adults and L1 larvae 
were removed the following day with M9.  Remaining eggs were synchronized with a 4 to 6 hour 
hatch, with the L1s being transferred to new RNAi plates.  Animals were then allowed to 
develop at 15°C until the L3 larval stage followed by a shift to 25°C to bypass the dauer 
induction of daf-2 knockdown.  Animals were left at 25°C overnight and then assayed for GFP 
localization.  L4440 was used as the empty vector control.  Images were taken using a Zeiss 
ApoTome with AxioVision software and a 20X objective.  Exposure times were kept consistent 
across strains within each experiment.  GFP localization was categorized as low, medium, or 
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high.  Statistical comparisons (chi-square test) were performed using GraphPad Prism 7 
software.  n>40 per strain, repeated in duplicate. 
3.D. Results 
     3.D.i. DBL-1/BMP Signaling Promotes Dauer Formation in a DAF-2/IIS-Sensitized 
Background 
Since we discovered that DBL-1/BMP and DAF-2/IIS pathways interact to regulate lipid 
accumulation, we sought to further characterize the relationship between the DBL-1/BMP and 
DAF-2/IIS pathways. We first observed dauer formation in animals containing mutations in both 
pathways.  As the dauer-phenotype of daf-2(e1370) mutation is temperature sensitive, we 
measured dauer induction at the restrictive temperature, 25°C, and the semi-permissive 
temperature, 20°C.  Normally, the DBL-1/BMP pathway has no effect on dauer, as dbl-1 
mutants, and other mutants in the pathway, have no observable dauer phenotype.  As expected, 
when we placed sma-3 or lon-2 mutants at 25°C, we observed no dauer progeny, as in our WT 
control.  When daf-2 mutants were placed at the restrictive temperature, we observed dauer 
induction in 98.4±0.7% of progeny, similar to previously published data.  This phenotype was 
also observed in the daf-2;sma-3 and daf-2;lon-2 mutants, with 99.5±0.6% and 97.6±1.7% dauer 
formation respectively. 
However, when animals were grown at the semi-permissive temperature, 20°C, DBL-1/BMP 
signaling had an observable impact on dauer formation in daf-2 mutants.  Again, the sma-3 and 
lon-2 mutants and WT had no dauer induction at 20°C.  The daf-2 mutants exhibited 54.5±6.3% 
dauer progeny at the permissive temperature.  The daf-2;sma-3 double mutants exhibited  
23.9±4.6% dauer formation, while the daf-2;lon-2 double mutants exhibited 73.4±7.3% dauer 
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formation (Table 3.1).  Two-way ANOVA indicates a significant (p=0.0006) interaction between 
the two pathways.  This result indicates that DBL-1/BMP signaling has a significant effect on 
dauer formation in DAF-2/IIS-sensitive background.  DBL-1/BMP signaling appears to 
modulate dauer formation in a dose-dependent manner, where reduced signaling, as in daf-2;dbl-
1 mutants, reduces occurrence of dauers, while increased signaling, as in daf-2;lon-2 mutants, 
increases dauers. 
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Percentage dauer arrest by daf-2;sma-3 mutants 
20°C 25°C 
Strain   Daf-c N   Daf-c N   
N2 0 239 0 228 
sma-3(wk30) 0 243 0 178 
lon-2(e678) 0 269 0 214 
daf-2(e1370) 54.5 ± 4.5 273 98.4 ± 0.5 236 
daf-2(e1370);sma-3(wk30) 23.9 ± 3.3 200 99.6 ± 0.4 221 
daf-2(e1370);lon-2(e678)   73.5 ± 5.2 317   97.6 ± 1.2 199 
 
Table 3.1. DBL-1 Pathway Modulates Dauer Constitutive Phenotype of daf-2 Mutants at 
20°C.  In a WT background, DBL-1 signaling exerts no visible effect on dauer induction at both 
20°C and 25°C.  However, in a DAF-2-sensitized background, DBL-1 signaling promotes dauer 
induction at 20°C.  This effect is lost when observed at 25°C, where the loss of DAF-2 signaling 
is most potent.  Values given are percent dauer larva of total progeny ± SEM.  
C. ELEGANS DBL-1 IS A CONTEXT-DEPENDENT REGULATOR OF IIS 
69 
 
     3.D.ii. DBL-1/BMP Signaling Enhances Autophagic Induction in a DAF-2/IIS-Sensitized 
Background 
Autophagy is a cellular process involved in the recycling of cellular debris and other material, 
and is vital for the maintained health of an organism (Meléndez and Levine 2009).  As a known 
regulator of autophagy, DAF-2/IIS acts to suppress the induction of autophagosome formation, 
with daf-2 mutants exhibiting increased levels of autophagy.  Additionally, autophagy is required 
for proper dauer development in daf-2 mutants (Meléndez et al. 2003).  Autophagy was 
measured through the use of GFP::LGG-1, an autophagosome reporter (Palmisano and Meléndez 
2016).  LGG-1/LC3 is a protein involved in the formation, elongation, and fusion of 
autophagosomes (Meléndez et al. 2003).  Normally cytosolic, when autophagic conditions are 
induced, GFP::LGG-1 becomes localized to autophagosomes.  Localization of GFP::LGG-1 was 
observed in hypodermal seam cells.  The seam cells form a row of cells that run the length of the 
hypodermis on each lateral side of the animal.  Seam cells were observed due to their size and 
ease in imaging. 
When observed in a dbl-1 mutant background, there were very few observable autophagosome 
structures, with an average of only 0.91±0.11 punctae per cell, which was not significantly 
different from WT (1.11±0.09, p=0.2045).  lon-2 mutant animals exhibited a similar low basal 
level of autophagy, with only 0.90±0.08 punctae per seam cell, similar to that of dbl-1 
(p=0.9555) and WT (p=0.1147) (Figure 3.1A,B).  This result indicates that DBL-1/BMP 
signaling does not significantly affect basal levels of autophagy; however, as there is very little 
autophagy occurring in WT animals, we wanted to observe the effects of DBL-1/BMP signaling 
in an autophagy-induced background.  daf-2 mutants are known to show increased levels of 
autophagy (Meléndez et al. 2003).  To determine if DBL-1/BMP signaling would behave 
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similarly in the regulation of autophagy as it did with dauer formation, we grew the animals at 
20°C.  We observed an average of 5.51±2.42 punctae per seam cell in daf-2 mutants.  In daf-
2;dbl-1 mutants, the average was decreased to 3.85±2.20 (p<0.0001), while in daf-2;lon-2 
mutants the average was increased to 6.90±2.75 (p<0.0001) (Figure 3.1C,D).  As similarly seen 
in dauer formation, DBL-1/BMP signaling only induces a phenotype in a DAF-2-compromised 
background, and antagonizes DAF-2 signaling in dose-dependent manner. 
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Figure 3.1. DBL-1 Signaling Promotes Autophagy in a DAF-2-Sensitized Background. A) 
DBL-1 signaling does not significantly affect basal rates of autophagy, as both dbl-1 and lon-2 
mutants are not significantly different from WT.  B) When autophagy is induced, via a reduction 
in DAF-2 signaling, DBL-1 signaling promotes autophagy, as dbl-1 mutants show a reduction in 
GFP puncta, while lon-2 mutants show a reduction in puncta.  C) Images of GFP::LGG-1 
localization in seam cells of DBL-1 pathway mutants under basal autophagy conditions at 630X. 
White arrow denotes an example of a GFP::LGG-1 punctae.  D) Images of GFP::LGG-1 
localization in seam cells of DBL-1 pathway mutants under autophagic induction via daf-2 
mutant background at 630X.  All animals were grown at 20°C and imaged at the L3 larval stage.  
For all graphs, n.s. not significant, *** p value < .001, boxes denote 2nd and 3rd quartiles, 
whiskers denote min and max values.  
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     3.D.iii. Loss of DBL-1/BMP Signaling Attenuates the Longevity Phenotype of DAF-2/IIS 
The DBL-1/BMP has been shown to have a slight effect on longevity; however, it has mainly 
been attributed to dbl-1 mutants’ poor innate immunity response.  Conversely, DAF-2/IIS is 
well-known for its role in longevity and survival, with daf-2 mutants living well beyond control 
animals (Kimura et al. 1997; Tissenbaum and Ruvkun 1998).  To further elucidate the interaction 
of both pathways, we tracked the survival of worms at 25°C.  Here we observe sma-3 mutants as 
having a slight reduction in median survival, 8 days post-L4, compared to control, 11 days post-
L4, which was not statistically significant (p=0.1761).  Meanwhile, the daf-2 mutants animals 
had a mean survival of 30 days post-L4, significantly increased compared to control (p<0.0001).  
The double mutant, daf-2;sma-3, exhibited a mean survival of 15 days.  This was significantly 
reduced from the daf-2 mutants (p<0.0001), indicating that DBL-1/BMP signaling is antagonist 
to DAF-2/IIS in a DAF-2 compromised background (Figure 3.2). 
The combined observations present above, coupled with previous work from our lab (Clark et al. 
2018), identifies three modes of interaction between DBL-1/BMP signaling and DAF-2/IIS: 
independent, epistatic, and antagonistic.  As discussed in Clark et al. 2018, we observed 
independent effects on body size, as animals containing simultaneous mutations in both 
pathways resulted in intermediate lengths.  Epistatic effects were observed in the regulation of 
lipids with the high-fat phenotype of daf-2 mutants completely masking the low-fat phenotype of 
sma-3 when observed in daf-2;sma-3 mutants.  Lastly, the data observed in this study reveals a 
third relationship between the two pathways; DBL-1/BMP signaling appears to antagonistically 
affect DAF-2/IIS phenotypes.  However, these effects are only observed in a DAF-2/IIS-
compromised background, as mutations only in the DBL-1 pathway do not result in observable 
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phenotypes.  To elucidate the mechanism by which DBL-1/BMP interacts with DAF-2/IIS, we 
explored interactions both upstream and downstream of daf-2.    
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Figure 3.2.  Loss of DBL-1 signaling reduces the longevity phenotype of daf-2 mutants.  The 
average lifespan of sma-3 mutants (8 days) was not significantly different than that of the control 
(11 days, p=0.1761).  As previously published by multiple groups, we observed a large increase 
in the average lifespan of daf-2 mutants (30 days).  This increase in lifespan was significantly 
reduced in the daf-2;sma-3 mutants (15 days) compared to daf-2 alone (p<0.0001).   
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     3.D.iv. ins-4p Driven Expression of GFP is Up-regulated in the Hypodermis upon the 
Loss of SMA-3 
In a previously published microarray, our lab identified ins-4 as a down-regulated gene in both a 
dbl-1 and sma-9 mutant backgrounds (Liang et al. 2007). To observe INS-4 regulation, we 
obtained an ins-4p::gfp reporter and crossed it into a sma-3 mutant background.  In WT animals 
carrying the ins-4p::gfp reporter, GFP is visible in neurons while only faint GFP expression was 
observed in hypodermis.  However, in sma-3;ins-4p::gfp animals, GFP expression was starkly 
increased in the hypodermis, indicating an increase in ins-4 expression (Figure 3.3A).  This 
observation would indicate that DBL-1/BMP signaling normally down-regulates the expression 
of ins-4, corroborating the data from the microarray.  We have previously proposed the theory 
that DBL-1/BMP signaling is regulating the expression of insulin-like peptides (ILPs) through 
SMAD signaling in the hypodermis, with the ILPs then regulating lipid accumulation through 
DAF-2/IIS in the intestine (Clark et al. 2018).  As GFP expression was increased in the 
hypodermis in sma-3;ins-4p::gfp animals, this would indicate that SMAD regulation of ins-4 
transcription is occurring in the hypodermis, as proposed. 
     3.D.v. ins-4 Exhibits a Lipid Accumulation Phenotype Epistatic to dbl-1 
If INS-4 acts as the mediator between SMAD signaling in the hypodermis, and DAF-2 signaling 
in the intestine, it should be required for normal lipid accumulation.  Therefore, we measured 
lipid accumulation in ins-4 mutant animals via Oil Red O staining.  We observed an increase of 
~20% in the ins-4 mutants compared to wild type (p=0.0016).  This increase in the ins-4 mutants 
mimics the increase in lipid accumulation observed in daf-2 mutants.  As previously published, 
we saw a significant decrease in sma-3 animals by ~42% (p<0.0001).  To test the proposed 
epistatic interaction between sma-3 and ins-4, we generated a sma-3;ins-4 double mutant and 
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determined its phenotype.  Interestingly, we saw a significant increase in staining of the sma-
3;ins-4 double mutants by ~35% compared to wild type (p<0.0001) (Figure 3.3B,C).  These 
results indicate that the loss of ins-4 is sufficient to significantly alter the level of lipids in the 
intestine.  Additionally, the loss of ins-4 reverses the loss of lipids in a sma-3 mutant 
background, instead resulting in an increased level of lipids compared to wild type.  These 
findings implicate INS-4 as the target of action for DBL-1/BMP signaling to regulate lipid 
storage through DAF-2/IIS. 
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Figure 3.3. INS-4 acts downstream of SMA-3 to regulate lipid metabolism. A) Images of 
animals expressing ins-4p::GFP.  Control animals displayed ins-4p::GFP in head neurons, with 
faint expression in the hypodermis.  Upon loss of sma-3, ins-4p::GFP expression is significantly 
increased in the hypodermis.  Images taken at 200X, camera settings were kept constant between 
all strains.  B) Loss of ins-4 results in an increase in intestinal lipid stores via Oil Red O staining, 
this increase is epistatic to the low-fat phenotype of sma-3 mutants.  Animals were grown at 
20°C and stained at the L4 larval stage. Quantification was done for equivalent regions of the 
intestine just posterior to the pharynx.  C) Images of L4 animals stained with Oil Red O taken at 
400X. Anterior is to the left.  For all graphs, asterisks across the bottom denote significance 
compared to Control, n.s. not significant, *** p value < .001, boxes denote the 2nd and 3rd 
quartiles, whiskers denote min and max values. 
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     3.D.vi. Loss of DBL-1/BMP Signaling Alters Localization of Transcription Factors 
Downstream of DAF-2/IIS 
The up-regulation of ins-4 upon loss of dbl-1 or sma-9 (Liang et al. 2007), coupled with the 
increase in hypodermal ins-4p::gfp in a sma-3 mutant background, and increased Oil Red O 
staining in sma-3;ins-4 mutants (Figure 3.3) all explain the epistatic interaction of DBL-1 and 
DAF-2 signaling for lipid accumulation, but it does not elucidate the antagonistic relationship 
seen in the dauer formation, autophagy, and longevity phenotypes.  To determine whether DBL-
1 signaling affected DAF-2/IIS outside of regulating ins-4 expression, we observed the 
localization of transcription factors known to play major roles in the regulation of genes 
downstream of the receptor, DAF-2.   
When DAF-2/IIS is activated, both DAF-16/FOXO and SKN-1/Nrf are phosphorylated and 
excluded from the nucleus; however, upon down-regulation of DAF-2/IIS, both transcription 
factors are shuttled into the nucleus (Ogg et al. 1997; Tullet et al. 2008).  To observe any 
alterations to this translocation, we crossed SKN-1::GFP into a dbl-1 mutant background and 
treated animals with daf-2 RNAi.  Localization of the two transcription factors was observed in 
the intestinal nuclei due to their size and prominence.  In a wild-type background, animals 
treated with the empty vector, L4440, exhibited mainly diffuse expression of SKN-1::GFP, with 
very few animals containing nuclear localization.  However, upon treatment with daf-2 RNAi, 
the majority of animals showed a significant increase in nuclear SKN-1::GFP (p<0.0001).  This 
responsiveness to the reduction of DAF-2/IIS was lost in the dbl-1 mutant background.  When 
treated with L4440, dbl-1 mutants exhibited an increased level of nuclear localization compared 
to the wild-type control (p=0.0073), but less than that of wild type treated with daf-2 RNAi 
(p<0.0001).  Interestingly, upon treatment with daf-2 RNAi, localization of SKN-1::GFP in dbl-1 
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mutants was not significantly different from those treated with the empty vector (p=0.8694) 
(Figure 3.4A,B).   
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Figure 3.4. SKN-1::GFP localization is altered in dbl-1 mutants regardless of DAF-2/IIS.  
A) Control animals treated with empty vector exhibit very little nuclear localization of SKN-
1::GFP, upon treatment with daf-2 RNAi, SKN-1::GFP nuclear localization drastically increases.  
In dbl-1 mutants, SKN-1::GFP nuclear localization is slightly increased compared to the control 
under empty vector treatment, upon treatment with daf-2 RNAi, no change in nuclear 
localization is observed.  Nuclear localization was graded as high, medium, or low, with an 
example of each ranking shown. Asterisks across the bottom represent significance compared to 
Control, n.s. not significant, ** p<.01, *** p<.001, error bars represent SEM.  B) Images of 
animals expressing SKN-1::GFP taken at 200X.  White arrows indicate examples of nuclei, red 
arrows indicate SKN-1::GFP expression in ASI neurons.  Camera settings were identical 
between all strains.  
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3.E. Discussion 
Our lab has previously shown that DBL-1/BMP signaling and DAF-2/IIS interact to regulate 
lipid stores in C. elegans (Clark et al. 2018).  In this study, we develop that interaction further by 
presenting evidence that DBL-1/BMP signaling exhibits an antagonistic effect on dauer 
formation, autophagy, and longevity in a DAF-2/InsR mutant background.  We show that daf-
2;sma-3 mutants have a reduction in both the rate of dauer formation and autophagy, as seen 
through GFP::LGG-1 punctae, at 20°C compared to daf-2 mutants; additionally, daf-2;sma-3 
mutants exhibit a significant reduction in extended lifespan normally seen in daf-2 single 
mutants when grown at 25°C.  Mutations in the DBL-1/BMP pathway do not exhibit any of these 
phenotypes on their own, indicating that a DAF-2-compromised background is necessary for 
DBL-1/BMP signaling to exhibit a measurable effect.  These data also indicate that the 
mechanism by which DBL-1/BMP signaling modulates the dauer, autophagy, and longevity 
phenotypes is distinct from that of lipid regulation. 
Through epistasis analysis, our original study showed that DBL-1/BMP functions upstream of 
DAF-2/IIS, as daf-2;sma-3 mutants exhibited a similar high-fat phenotype as daf-2 mutants, 
significantly different from that of the low-fat dbl-1 mutants.  We also presented evidence that 
this relay between the two pathways was happening in a non-cell autonomous fashion, proposing 
that DBL-1/BMP signaling regulated the expression of insulin-like peptides (ILPs) in the 
hypodermis, which then fed into DAF-2/IIS in the intestine.  A previously published microarray 
from our lab indicated that expression of two ILPs, INS-4 and INS-7, were down-regulated in 
both a dbl-1 and sma-9 mutant background (Liang et al. 2007).  In this study, we examined the 
hypodermally expressed INS-4, as a possible link between the two pathways.  Using an ins-
4p::gfp reporter, we show that expression of GFP is highly increased in the hypodermis in a sma-
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3 mutant background, indicating that SMAD signaling regulates ins-4 expression in the 
hypodermis.  Additionally, we show that ins-4 mutants have increased levels of lipids, and that 
sma-3;ins-4 mutants exhibit a similar increase in lipid stores.  These data provide evidence that 
DBL-1 activates SMAD signaling in the hypodermis, down-regulating the expression of INS-4, 
to reduce DAF-2/IIS in the intestine, in turn, maintaining proper lipid stores (Figure 3.5A). 
The connection through INS-4, however, does not explain the effect of DBL-1/BMP signaling on 
dauer formation, autophagy, or longevity.  As animals with mutations in both pathways show 
distinct phenotypes from daf-2 single mutants, a linear epistatic relationship could not explain 
these data.  Instead, we show that the loss of DBL-1/BMP signaling has a direct effect on the 
sub-cellular localization of SKN-1.  In a wild-type animal, DAF-16/FOXO and SKN-1/Nrf 
localization are responsive to DAF-2/IIS; when DAF-2/IIS is activated, both transcription factors 
are excluded from the nucleus and maintained in the cytoplasm, however, when DAF-2/IIS is 
low they are able to enter the nucleus and regulate their respective targets.  This study presents 
evidence that the responsiveness of SKN-1 to DAF-2/IIS is lost in a dbl-1 mutant background.  
In dbl-1 mutants treated with both empty vector and daf-2 RNAi, SKN-1::GFP localization is not 
significantly altered.  If DBL-1/BMP signaling only affected DAF-2/IIS through regulation of 
ILPs, we would expect to see increased cytoplasmic SKN-1::GFP in a dbl-1 mutant and 
increased nuclear SKN-1::GFP following treatment with daf-2 RNAi.  However, the lack of 
change in localization indicates that DBL-1/BMP signaling may be directly affecting the 
localization independent of DAF-2/IIS.  The mechanism by which this effect on localization 
occurs still requires elucidation. 
A recent publication from the Baumeister group details how DBL-1/BMP signaling interacts 
with DAF-16 to induce germline tumor formation.  Through both yeast-two-hybrid assay and co-
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immunoprecipitation, DAF-16 was shown to bind SMA-2 and SMA-3 directly (Qi et al. 2017).  
Direct binding of the R-Smads to DAF-16 would provide a possible mechanism to explain our 
findings.  The Qi et al. 2017 publication postulates that the co-binding of SMADs with DAF-16 
at target genes helps to promote the activity of DAF-16.  Our data presented here align with this 
hypothesis; as nuclear DAF-16 promotes dauer induction, autophagy, and longevity, the loss of 
sma-3 would result in lower DAF-16 activity and therefore a reduction in each of the 
aforementioned phenotypes, as we observed in a daf-2;sma-3 mutant background.   
Additionally, the study found that both pathways have an impact on the expression of daf-
15/Raptor, rheb-1/Rheb, and rsks-1/S6k, all genes important for the target of rapamycin complex 
1 (TORC1), in addition to having overlap in the regulation of over 750 genes as observed 
through microarray analysis (Qi et al. 2017).  TORC1 is a key regulator of autophagy that lies 
downstream of DAF-2/IIS.  Our data showing the alteration of autophagy induction in DBL-
1/BMP pathway mutants reinforces the finding that TORC1 genes are transcriptional targets of 
the pathway. The necessity of compromised DAF-2/IIS also highlights the fact that DBL-1/BMP 
signaling is interacting downstream to regulate TORC1, rather than through DAF-2/IIS. 
In this study we have provided further evidence to expound upon the interactions between DBL-
1/BMP signaling and DAF-2/IIS.  To date, three modes of co-regulation between the two 
pathways have been observed.  Independent regulation has been observed in body size 
determination and reproductive aging, where both pathways contribute to observed phenotypes 
in parallel to each other (Luo et al. 2010; Clark et al. 2018).  The data presented here and in our 
previous paper outline a second mode of interaction.  We show that DBL-1/BMP signaling 
regulates the expression of ins-4 in the hypodermis to impact the regulation of lipid accumulation 
in the intestine through DAF-2/IIS (Figure 3.5A).  Data highlighting an inverse relationship have 
C. ELEGANS DBL-1 IS A CONTEXT-DEPENDENT REGULATOR OF IIS 
84 
 
also been shown, where DBL-1/BMP actually functions downstream of DAF-2/IIS to promote 
somatic development, as DBL-1/BMP activity is required for the L1 arrest defective phenotype 
of daf-16 mutants (Kaplan et al. 2015).  Lastly, we uncovered a third mode of interaction, where 
DBL-1/BMP signaling affects multiple daf-2-associated phenotypes through interactions 
downstream of daf-2/InsR.  We provide evidence of a possible mechanism in which altered 
DBL-1/BMP signaling affects the sub-cellular localization of SKN-1.  Therefore, we propose 
that DBL-1 signaling may be affecting multiple transcription factors downstream of DAF-
2/InsR, either through direct interaction or indirectly through other mediators.  However, we 
believe the effect of DBL-1/BMP is only observable in a DAF-2/IIS-compromised background, 
as the inhibition by active DAF-2/IIS overpowers the antagonistic effect of DBL-1/BMP (Figure 
3.5B,C). 
Together, these interactions exemplify the interconnected, polymodal nature both DAF-2/IIS and 
DBL-1/BMP signaling that rely upon the context of animal to dictate function.  The homeostatic 
regulation of cellular processes, such as metabolism and autophagy, are vital to the well-being of 
an organism and must be flexible enough to coordinate a vast variety of inputs and outputs.  In 
humans, the interweaving of multiple pathways provides a challenge for elucidating the effects 
specific pathways in relation to diverse inputs and contexts.  Using C. elegans, we have 
developed a model to understand the relationship of two highly conserved pathways, BMP and 
Insulin/IGF-1, and how the balance of their effects is context-dependent. 
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Figure 3.5. DBL-1 can function in both an epistatic and antagonistic manner to DAF-2.  A) 
SMAD signaling in the hypodermis regulates the transcription of ins-4, which in turn feeds into 
DAF-2/IIS in the intestine to control lipid metabolism.  B)  When DAF-2/IIS signaling is intact, 
DAF-2 prevents the function of DAF-16 and SKN-1, and suppresses possible effects of DBL-1 
on their activity.  C)  When DAF-2/IIS is compromised, as in a daf-2 mutant, the negative 
regulation of DAF-16 and SKN-1 by DAF-2 is lost, allowing the effects of positive regulation by 
DBL-1 to become visible.  Dashed arrow indicates potential direct or indirect influence. 
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4. Discussion and Future Directions 
The TGF-β signaling superfamily is a well-characterized regulator of early development and 
differentiation.  As the founding, ancestral member of this family, BMP is rooted in early axis 
determination and tissue patterning.  However, recent studies continue to provide evidence that 
BMP signaling plays an important role in maintaining the well-being of an organism post-
development.  In this dissertation, I have shown that DBL-1, the C. elegans BMP2/4 ortholog, 
plays an integral role in maintaining lipid stores.  In addition, I have provided evidence that 
DBL-1 signaling can affect dauer induction, autophagy, and longevity in a DAF-2/IIS-
compromised genetic background.  Together, these data indicate a clear role for DBL-1 signaling 
and its continued importance post-developmentally to regulate homeostatic functions. 
4.A. DBL-1 Signaling is Required for Lipid Homeostasis 
     4.A.i. DBL-1 Promotes Proper Lipid Storage and Lipid Droplet Morphology 
As discussed in chapter two, we provide the first evidence in C. elegans that DBL-1 signaling 
has a direct impact on lipid storage.  Both a decrease, i.e. dbl-1 and sma-3 mutants, and an 
increase, i.e. lon-2 and dbl-1(OE) mutants, in DBL-1 signaling results in a significant reduction 
in lipid stores (Figure 2.1).  This indicates that  any alteration to wild-type levels of signaling is 
detrimental to lipid maintenance.  The loss of lipids in DBL-1 pathway mutants is similar to that 
of fat-6;fat-7 mutants.   
FAT-6 and FAT-7 are Δ9 fatty acid desaturases responsible for the first desaturation event in 
converting 18-carbon saturated fatty acids into complex polyunsaturated fatty acids (Figure 1.2); 
both fat-6 and fat-7 were found to be down-regulated in both dbl-1 and sma-9 mutant 
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backgrounds (Liang et al. 2007).  A preliminary GC-MS trial indicated that sma-3 mutants had 
an increase in the ratio of stearic acid (C18:0) to oleic acid (C18:1Δ9), with an overall decrease 
in TAGs, similar to that of previously published data on fat-6;fat-7 mutants. We therefore 
propose that a loss of DBL-1 signaling results in improper lipid synthesis and subsequent 
storage, resulting in decreased lipid levels (Figure A2). 
Additionally, I showed that lipid droplet morphology in dbl-1 mutants is significantly altered 
compared to wild type.  When DBL-1 signaling is decreased, as in a dbl-1 mutant, both the 
quantity and diameter of lipid droplets is decreased.  Increased DBL-1 signaling, as in the dbl-
1(OE) background, also results in a reduction of the quantity of lipid droplets, however, the 
average diameter is actually increased compared to wild type.  Coupled with the overall lipid 
stores observed via Oil Red O, we conclude that a goldilocks-zone of DBL-1 signaling is 
required to maintain wild-type lipid stores.  However, the disconnect between the number of 
droplets and their average diameter alludes to a delineation of mechanism between decreased and 
increased DBL-1 signaling activity, while still resulting in an overall decrease in lipids. 
     4.A.ii. β-Oxidation and Mitochondrial Fitness 
In the initial microarray performed in both dbl-1 and sma-9 mutant background that identified 
fat-6, fat-7, and ins-4 as target genes of DBL-1 signaling, numerous genes involved in β-
oxidation were noted (Liang et al. 2007).  We have shown that dbl-1 mutants display a reduced 
level of lipid stores, similar to that of fat-6;fat-7 mutants.  The loss of lipids in fat-6;fat-7 
mutants is thought to be a combination of both abnormal lipid synthesis and an increased level of 
β-oxidation activity (Watts 2009).  Interestingly, NHR-49, a nuclear hormone receptor, is a 
transcription factor involved in the regulation of fat-7 and multiple β-oxidation genes; loss of 
NHR-49 activity results in an increase in β-oxidation rates and lipid stores (Van Gilst et al. 
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2005).  At the regulatory level, lipid desaturation and β-oxidation seem to be inexorably linked, 
with alterations to one process causing direct effects on the other. 
The activity of β-oxidation also plays an integral role in lipid droplet morphology.  ATGL-1, the 
C. elegans ortholog of mammalian ATGL, localizes to lipid droplets and initiates the lipolysis of 
TAGs.  RNAi of atgl-1 results in high levels of lipid stores as well as the inability to mobilize 
lipids in response to fasting (Lee et al. 2014).  Downstream of ATGL-1 activity lies the MAOC-
1/DHS-3/DAF-22 peroxisomal β-oxidation pathway, involved in the breakdown of long-chain 
fatty acids.  Disruptions within the MAOC-1/DHS-3/DAF-22 pathway result in animals with 
enlarged lipid droplets (Li et al. 2016).  Interestingly, the microarray that uncovered fat-6 and 
fat-7 also showed an up-regulation of maoc-1 in a dbl-1 mutant background (Liang et al. 2007).  
This result hints that there may be an increase in β-oxidation in dbl-1 mutants, in addition to a 
reduction in lipid synthesis.  A recent paper concurrently identified the role of DBL-1 signaling 
in lipid homeostasis; the regulation was attributed to mitochondrial β-oxidation, as multiple 
mitochondrial β-oxidation genes were induced in both a sma-2 and sma-4 mutant background in 
addition to alterations in mitochondrial morphology (Yu et al. 2017).  Taken together, our results 
and those of the Wang lab indicate that DBL-1 pathway mutants exhibit decreased lipid stores 
via improper lipid synthesis and increased β-oxidation. 
     4.A.iii. SMAD Signaling in the Hypodermis Regulates Intestinal Lipid Stores 
Expression of dbl-1 is limited to a handful of neurons and muscle, and the ligand is secreted to 
target tissues (Suzuki et al. 1999).  Meanwhile, the Smads and receptors, including the R-Smad, 
sma-3, are expressed in the pharynx, intestine, and hypodermis. Previously published data 
identifies the importance of SMAD signaling in the hypodermis to regulate the body size 
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phenotype of DBL-1 signaling mutants.  Expression of SMA-3 solely in the hypodermis was 
sufficient to rescue the small body size phenotype of sma-3 mutants (Wang et al. 2002). 
We show that the same pattern is seen in the regulation of lipids.  Expression of SMA-3 in the 
hypodermis is sufficient to rescue intestinal lipids to wild-type levels, while expression in the 
intestine could not rescue (Figure 2.2) (Clark et al. 2018).  This observation indicates a non-cell 
autonomous signaling mechanism that relays active SMAD signaling in the hypodermis to 
regulate expression of genes in the intestine, as fat-7 is solely expressed in the intestine.  fat-6 is 
expressed both in the intestine and the hypodermis (Brock et al. 2006).  Both fat-6 and fat-7 are 
direct targets of DAF-16/FOXO, and are up-regulated upon the loss of DAF-2/IIS (Ogg et al. 
1997).  Loss-of-function daf-2 mutants are well-known for their high fat phenotype (Kimura et 
al. 1997).   
As both ins-4 and ins-7 were found to be up-regulated in the dbl-1 and sma-9 microarrays (Liang 
et al. 2007), we postulated that DBL-1 signaling may be regulating lipid stores through DAF-2.  
Using epistasis analysis, we confirmed that DAF-2 signaling functions downstream of DBL-1 
signaling to regulate lipid stores, as daf-2;sma-3 and daf-2;lon-2 mutants both show the same 
increase in lipids as daf-2 single mutants, completely masking the low-fat phenotype of either 
sma-3 or lon-2 single mutants (Figure 2.3) (Clark et al. 2018).  We opted to examine ins-4 as a 
candidate intermediary; ins-4 is expressed at low levels in both the hypodermis and the intestine, 
while ins-7 is not expressed in the hypodermis and is a known target of DAF-2 signaling, 
thought to be part of a positive-feedback loop (Ritter et al. 2013).  Using GFP driven by the ins-4 
promoter, we observed a stark increase in GFP expression in the hypodermis in a sma-3 mutant 
background (Figure 3.3).  This increase in ins-4p-driven GFP in sma-3 mutants confirmed the 
down-regulation of ins-4 by active DBL-1 signaling.  To determine if ins-4 was the mediator for 
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lipid homeostasis, we compared lipid levels in ins-4 and sma-3;ins-4 mutants; ins-4 mutants had 
a significant increase in lipid stores compared to wild type and was epistatic to the low-fat 
phenotype of sma-3 mutants (Figure 3.3).  The epistatic relationship mimicked that found 
between daf-2 and sma-3 (Figure 2.3), confirming ins-4 as a mode of action for DBL-1 
regulation of lipids through DAF-2/IIS. 
4.B. DBL-1 Signaling Modulates DAF-2 Signaling to Regulate an Array of 
Homeostatic Functions in C. elegans 
In the third chapter, I detail recent data that identifies a role for DBL-1 signaling in modulating 
DAF-2/IIS.  Initial findings from (Clark et al. 2018) identified an epistatic relationship between 
the two pathways to regulate lipid stores, with DAF-2 functioning downstream of DBL-1 
signaling.  Upon further examination we identified a range of phenotypes that are affected by 
changes in DBL-1 signaling in a daf-2 mutant background.  The loss of DBL-1 signaling 
antagonistically modulates the dauer formation, autophagy induction, and longevity phenotypes 
well-characterized in daf-2 mutants. 
By themselves, mutations in the DBL-1 pathway do not result in changes in dauer formation, 
autophagy, or longevity; phenotypes only arise in a daf-2-compromised background.  This 
indicates that on its own, DBL-1 signaling does not have a significant enough effect to compete 
with DAF-2/IIS, only when DAF-2 function is reduced can DBL-1 signaling exhibit an 
appreciable effect.  This interaction is distinct from that found in the regulation of lipids, where 
the reduction in DAF-2 activity was completely epistatic to DBL-1 signaling.  Supporting this, 
ins-4 mutants do not have a dauer phenotype on their own (Ritter et al. 2013); therefore, ins-4 
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could not be acting as a mediator between the two signaling pathways in regard to dauer 
formation. 
Instead, as loss of DBL-1 signaling works antagonistically to DAF-2/IIS, the data allude to the 
interaction of DBL-1 signaling downstream of daf-2.  Additionally, increased DBL-1 signaling 
in lon-2 mutants enhanced the dauer and autophagy phenotypes in daf-2 mutants, indicating that 
DBL-1 signaling modulates these phenotypes in a dose-dependent manner, unlike lipid 
homeostasis.  We therefore wanted to explore possible effects of DBL-1 signaling on the 
transcription factors downstream of DAF-2/IIS.  The most well-characterized transcription 
factor, DAF-16/FOXO, is required for the majority of the phenotypes observed in daf-2 mutants; 
loss of daf-16 in a daf-2 mutant background attenuates the dauer, longevity, stress response, 
innate immunity, and high-fat phenotypes normally observed (Ogg et al. 1997).  SKN-1/Nrf2 is 
another transcription factor downstream of daf-2 and works in parallel with DAF-16 to promote 
longevity, innate immunity, and stress response (Tullet et al. 2008). 
     4.B.i. DBL-1 Impacts Autophagy in a Dose-Dependent Manner 
Autophagy is a conserved cellular process which is responsible for the recycling of unwanted 
material.  Autophagy involves the formation of an autophagosome that encases the unwanted 
material and then fuses to a lysosome to induce degradation.  A vitally significant process, 
disruptions to autophagy results in multiple developmental phenotypes; with severe disruptions 
resulting in larval arrest (Meléndez and Levine 2009).  Autophagy is also required for longevity, 
as knockdown of autophagy-related genes shortens the increased longevity of daf-2 mutants.  
Additionally, daf-2 mutants exhibit increased levels of autophagy compared to wild-type worms 
(Meléndez et al. 2003). 
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Much as the loss of sma-3 reduced the longevity phenotype of daf-2 mutants, we showed that 
alterations in DBL-1 signaling affect the levels of autophagy in a daf-2 mutant background.  We 
visualized autophagy through the use of a GFP::LGG-1 strain; LGG-1 is a protein involved in 
the vesicle elongation step of autophagy and localizes to the membrane of autophagosomes.  We 
showed that DBL-1 signaling regulates autophagy in a dose-dependent manner in daf-2 mutants; 
daf-2;dbl-1 animals had a reduction in GFP::LGG-1 punctae, while daf-2;lon-2 mutants had an 
increase.  However, changes in DBL-1 signaling had no significant effect on basal levels of 
autophagy, as the phenotype was only seen in a daf-2-compromised genetic background (Figure 
3.1).  We conclude that DBL-1/BMP signaling activity promotes autophagy when DAF-2/IIS is 
impaired.   
This conclusion differs from the findings from (Guo et al. 2014) which state that DBL-1/BMP 
signaling inhibits autophagy; GFP::LGG-1 punctae were increased in sma-3 RNAi treated 
animals compared to empty vector treated wild type, and mutant sma-3 repressed the SQST-
1::GFP accumulation phenotype of rpl-43 mutants, a response associated with increased 
autophagy.  There are two possible explanations for the conflicting results: developmental age 
and tissue specificity.  The animals examined in (Guo et al. 2014) were young adults while we 
examined L3 larvae; DBL-1/BMP may be regulating autophagy in opposing directions at 
different stages of development, depending upon the recruitment of various co-regulators in the 
nucleus by the active SMAD complex.  Alternatively, DBL-1/BMP may affect autophagy 
regulation base on the environment of different tissue types; we measured autophagy through 
GFP::LGG-1 punctae in the hypodermal seam cells while (Guo et al. 2014) observed GFP::LGG-
1 punctae in the intestine.   Again, recruitment of co-regulators may function in a tissue-specific 
manner to differentially regulate autophagy in various tissues.  To answer these questions, 
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GFP::LGG-1 punctae could be assayed in the seam cells of young adult animals or in the 
intestine of L3 larvae.  If age plays a role, then we would expect to see increased GFP::LGG-1 
punctae in the seam cells of young adult dbl-1 mutants; however, if tissue-specificity plays a role 
we would expect to see decreased GFP::LGG-1 punctae in the intestine of L3 dbl-1 mutant 
larvae. 
DAF-2/IIS is a known regulator of autophagy, thought to act through TORC1 activity.  Key 
components, such as daf-15/Raptor, rheb-1/Rheb, and rsks-1/S6k, have been shown to be targets 
of DAF-16 regulation (Qi et al. 2017).  Additionally, both daf-16 and skn-1 mutants exhibit 
reduced autophagy in autophagy-induced backgrounds (Meléndez et al. 2003; Mosbech et al. 
2013).  The study that identified TORC1 components as targets of DAF-16 also found that 
expression of those genes was also altered in a sma-6 mutant background (Qi et al. 2017).  These 
data coincide with our observations that daf-2;sma-3 mutants exhibit less autophagy compared to 
daf-2 mutants (Figure 3.1). 
     4.B.ii. Loss of DBL-1 Signaling Significantly Impairs the Longevity of daf-2 Mutants 
Very little research has been done on the effects of DBL-1/BMP signaling on longevity in C. 
elegans.  A paper from the Ewbank lab reported that dbl-1 mutants had a decrease in lifespan 
compared to wild type when grown on OP50 E. coli.  However, when the E. coli was first heat-
killed, the lifespan of dbl-1 mutants recovered, leading to the conclusion that the reduction in 
lifespan was due to the slight pathogenicity of OP50 in the presence of dbl-1 mutants’ 
compromised immune system (Mallo et al. 2002).  More recently, a study found that dbl-1 
mutants had a slightly decreased lifespan on OP50 E. coli, which was improved when fed the 
nutrient-rich HB101 E. coli strain.  The authors argue that the increased nutrient content and ease 
of digestion of HB101 accounts for the increased lifespan  (So et al. 2011). 
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In our lifespan assay, sma-3 mutants had a slight reduction in average lifespan but it was not 
significantly different from that of the control when grown on DA837 E. coli, as such we did not 
see any significant pathogenic effects.  Current unpublished work from our lab indicates that 
DAF-2/IIS is epistatic to DBL-1/BMP signaling for innate immunity regulation, as daf-2;sma-3 
mutants seem to survive as well as daf-2 mutants when grown on Db11 Serratia marcescens 
(Ciccarelli, E., unpublished).  This preliminary data supports our hypothesis that the loss of sma-
3 reduces the longevity of daf-2 mutants independent of immune response; if DBL-1/BMP acts 
through DAF-2/IIS to regulate innate immunity, then daf-2;sma-3 mutants should have similar 
longevity to daf-2 mutants on DA837.  As we did observe a significant reduction between the 
two mutant backgrounds, we conclude that the reduction is caused by alterations in longevity 
factors.  However, to clarify this hypothesis, the lifespan assay could be repeated with UV-killed 
DA837 to eliminate the possibility of pathogenic effects on longevity. 
Both DAF-16 and SKN-1 activity are required for the longevity phenotype of daf-2 mutants.  
Each of the transcription factors work in parallel to regulate a subset of target genes that promote 
longevity, with overlap found between the two.  We propose that the reduction in longevity of 
daf-2;sma-3 mutants may be due to reduced activity of DAF-16, SKN-1, or both, and is 
connected to the reduction in autophagy also seen in said mutants. 
4.C. The Effect of DBL-1 on Effectors Downstream of DAF-2 
     4.C.i. Direct Interaction with DAF-16 or SKN-1 Downstream of DAF-2 
Under normal conditions, both DAF-16 and SKN-1 are localized to the cytoplasm.  Active DAF-
2/IIS results in the phosphorylation of DAF-16 and SKN-1 by AKT-1/2 to maintain their 
cytoplasmic localization; meanwhile, reduced DAF-2/IIS prevents the phosphorylation of DAF-
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16 and SKN-1, allowing them to translocate into the nucleus.  However, our data show that in a 
dbl-1 mutant background, SKN-1 localization is no longer responsive to the loss of DAF-2/IIS, 
as observed using a GFP-tagged functional SKN-1 reporter (Figure 3.4).  This would indicate 
that DBL-1 signaling is affecting SKN-1 localization downstream of DAF-2/IIS.  The 
mechanism of this regulation is still unknown. 
One possible mechanism would be that the SMAD complex helps to stabilize SKN-1 in the 
nucleus.  SMADs act as transcription factors and all contain a DNA-binding domain, MH1, that 
is thought to associate with SMAD binding elements, SBEs, in the genome.  While normally 
associated with SMA-9, the C. elegans Schnurri1/2 ortholog, SMADs can associate with 
multiple different co-transcription factors to regulate target genes.  Therefore, it may be possible 
that SMADs co-localize with SKN-1 to regulate a subset of target genes. Nuclear SKN-1 
promotes longevity and increased stress response in parallel to DAF-16 in a daf-2 mutant 
background; therefore, if reduced SMAD activity negatively impacts the nuclear translocation of 
SKN-1, SMAD mutants should display reduced longevity and stress tolerance in a daf-2 mutant 
background.  Our observation of reduced longevity in daf-2;sma-3 mutants correlates with this 
hypothesis.  However, dauer induction is independent of SKN-1, relying on nuclear localization 
of DAF-16 to promote dauer formation in a daf-2 mutant background.  As such, to explain the 
modulation of the dauer phenotype in daf-2;sma-3 and daf-2;lon-2 mutants, we believe SMADs 
may be affecting the localization of DAF-16, in addition to SKN-1.  If DBL-1 signaling 
promotes DAF-16 nuclear localization, loss of DBL-1 signaling would result in fewer dauers, as 
seen in daf-2;sma-3 mutants, while increased DBL-1 signaling would result in more dauers, as 
seen in daf-2;lon-2 mutants. 
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As an additional source of information, the binding sites of the SMADs can be cross-referenced 
with the binding sites of DAF-16 or SKN-1.  Our lab previously performed ChIP-Seq on a 
GFP::SMA-3 strain to identify regions of the genome bound by SMA-3 (Madaan et al. 2017); 
fat-6 was identified as a direct target of SMA-3 binding.  As all published ChIP-seq data is 
publicly available through the modENCODE project (Celniker et al. 2009), it would be possible 
to access data sets for both DAF-16 and SKN-1.   Known direct targets involved in each of the 
phenotypes of either DAF-16 or SKN-1 can be compared to the SMA-3 data to identify co-
regulated genes. 
A recent study by the Baumeister lab (Qi et al. 2017) indicates that both SMA-2 and SMA-3 can 
directly bind DAF-16 and found that over 700 genes had altered expression in both a daf-16 and 
sma-6 mutant background.  However, they argue that the SMADs enhance the activity of nuclear 
DAF-16, rather than regulate the translocation of DAF-16; they observed no change in the 
localization of DAF-16 in a sma-6 mutant background.  However, they observed localization 
using a constitutively active variant of DAF-16, DAF-16(4A)::GFP rather than in a daf-2 mutant 
background; therefore, if SMADs only help to stabilize SKN-1 or DAF-16 in a daf-2-sensitized 
background, constitutively active DAF-16(4A) would circumvent the aid of SMADs. 
     4.C.ii. Indirect Action Mediated by MAPK Signaling 
Clues to this mechanism may be garnered from studies in other organisms.  While still not fully 
characterized, a handful of studies have explored the activation of mitogen-activated protein 
kinase (MAPK) cascades via TGF-β/BMP signaling.  In Xenopus and human cell culture, human 
X-chromosome-linked inhibitor of apoptosis (XIAP) was show to bind to both TGF-beta 
activated kinase 1 (TAB-1) and the BMP receptor complex of BMPR1A and ActRII (Yamaguchi 
et al. 1999).  TAB-1 is the activator of mitogen-activated protein kinase 7 (MAP3K7/TAK-1) 
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which has been shown to subsequently activate both c-Jun N-terminal kinase (JNK) and p38 
MAPK pathways (Derynck and Zhang 2003).  In C. elegans, the JNK ortholog, JNK-1, has been 
shown to directly bind and phosphorylate DAF-16, promoting nuclear translocation (Oh et al. 
2005; Mukhopadhyay et al. 2006).  Additionally, PMK-1, one of three C. elegans p38 orthologs, 
is required for the phosphorylation and nuclear localization of SKN-1 (Inoue et al. 2005).  As of 
yet, a direct link between BMP signaling and the JNK and p38 MAPK pathways has not been 
uncovered in C. elegans; however, the findings in this study indicate that DBL-1/BMP signaling 
is able to affect DAF-16 and SKN-1 independently of DAF-2/IIS.  Tangentially, the microarray 
that identified ins-4 as a target of the DBL-1/BMP pathway also indicates that sek-3, a MAP2K 
ortholog, is down-regulated in a sma-9 mutant background.  SEK-3 activates PMK-3, another C. 
elegans p38 ortholog, involved in ETC disruption-induced longevity.  Although the SEK-
3/PMK-3 cascade has been shown to act independently of SKN-1 (Munkacsy et al. 2016), it 
provides further precedent for interaction between DBL-1/BMP and p38 MAPK signaling. 
Further study is required to determine if DBL-1 can affect the activity of either JNK-1 or PMK-
1.   
As BMP signaling is thought to work upstream of JNK and p38 MAPK, antibodies specific to 
phosphorylated JNK and p38 can be used to assay via western blot for increased MAPK activity 
(Inoue et al. 2005; Oh et al. 2005).  We would expect to see a decrease in phosphorylated JNK or 
p38 in a dbl-1 mutant background, and an increase in a dbl-1(OE) background, if DBL-1 
promotes JNK or p38 MAPK signaling.  As both JNK and p38 have multiple homologs in C. 
elegans, each of the homologs would be assayed to determine if DBL-1 signaling effects only 
certain pathways or if it functions upstream of each one.  Additionally, as current evidence points 
to a SMAD-independent interaction  (Derynck and Zhang 2003) between BMP signaling and 
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MAPK signaling, the levels of phosphorylated JNK or p38 should be analyzed in SMAD 
mutants and compared to dbl-1 mutants.  If JNK and p38 activation are SMAD-independent, 
there should be no change in the levels of phosphorylated versus non-phosphorylated proteins. 
Both DAF-16 and SKN-1 can also be targeted to the nucleus via phosphorylation antagonistic to 
DAF-2/IIS.  Studies have shown that JNK signaling results in the phosphorylation of DAF-16 at 
residues unique from that of AKT-1/2-targeted phosphorylation.  Unlike AKT-1/2, 
phosphorylation by JNK promotes nuclear localization of DAF-16 (Oh et al. 2005).  SKN-1 is 
regulated in a similar fashion by p38 MAPK signaling, where phosphorylation by p38 results in 
nuclear localization (Inoue et al. 2005).  If DBL-1 signaling promotes the activation of JNK or 
p38 MAPK, loss of DBL-1 could result in a lack of nuclear localization for both DAF-16 and 
SKN-1.  Using a SKN-1::GFP strain, we have observed a distinct change in the localization of 
SKN-1 in a dbl-1 mutant background.  Additionally, loss of daf-2 via RNAi knockdown did not 
result in increased nuclear localization of SKN-1 in a dbl-1 mutant background, compared to a 
significant change observed in wild type (Figure 3.4).  Currently, we are in the process of 
constructing strains containing DAF-16::GFP to observe its nuclear localization in a dbl-1 
mutant background.  Additionally, we hope to cross the daf-2(e1370) mutation into the 
background of both dbl-1;skn-1::gfp and dbl-1;daf-16::gfp to observe the more potent loss of 
function of daf-2 compared to RNAi knockdown. 
4.D. Conclusions 
The evidence outlined above, and detailed in earlier chapters, clearly states a role for DBL-
1/BMP signaling in the maintenance of an organism’s well-being.  Recent research has continued 
to shed light on the role of BMP in homeostasis across multiple species.  Numerous homeostatic 
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pathways in C. elegans, such as Serotonin, DAF-7/TGF-β, and DAF-2/IIS, rely on external 
inputs to modulate their activity in response to the environment.  DBL-1/BMP, on the other 
hand, is a traditionally developmentally-dependent pathway, responding to intrinsic cues rather 
than external stimuli.  This then begs the question of why DBL-1/BMP is necessary to regulate 
homeostasis.  Here I have outlined a mechanism by which BMP signaling can communicate and 
interact with IIS at multiple junctions.  While continued exploration is necessary to elucidate the 
intricacies of these interactions, we have developed a model through which they can be 
examined. 
Proper regulation of homeostasis is integral for survival, reproduction, and health.  Disruptions to 
these pathways can result in a range of disorders in humans.  Metabolic disorders, stemming 
from obesity and insulin resistance, are an ever growing concern and have been impacting world 
health since their rise in the 1970s.  While the mechanism of insulin signaling is well-
characterized, the factors resulting in the onset of insulin resistance and type II diabetes are less 
so.  Continued study has uncovered new pieces in the balance of insulin regulation, such as 
BMP4 and BMP7; however, due to the complexity and integration of numerous pathways, 
deciphering the roles of specific pieces poses a significant challenge.  Examining these pathways 
in C. elegans alleviates many of these challenges, while still providing a robust, tractable, and 
complex model that continues to aid in the understanding of human physiology and genetics. 
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5. Materials and Methods 
5.A. C. elegans Strains and Maintenance 
All strains were maintained on DA837 E. coli grown on EZ worm mix media supplemented with 
100µl/ml streptomycin.  The majority of strains were maintained at 20°C; strains containing the 
mutation daf-2(e1370), or studied in conjunction with daf-2(e1370) strains, were maintained at 
15°C.  A full list of strains and genotypes is found below (Table 5.1). 
5.B. Oil Red O Staining 
Protocol adapted from (O'Rourke et al. 2009).  Animals were collected at the L4 stage in PCR 
tube caps and washed three times in PBS.  Worms were then fixed for 1 hour in 60% isopropanol 
while rocking at room temperature.  The isopropanol was removed and worms were stained 
overnight with 60% Oil Red O solution while rocking at room temperature.  Oil Red O was 
removed and the worms were washed once with PBS w/ .01% Triton and left in PBS.  Worms 
were mounted and imaged using an AxioCam MRc camera with AxioVision software.  Images 
were taken using a 40X objective.  Oil Red O stock solution was made with 0.25g Oil Red O in 
50mL isopropanol.  Intensity of the post-pharyngeal intestine was determined using ImageJ 
software. Pixel intensity was measured in the green color channel of the images.  Three 
measurements using a 50px by 50px area were taken for each worm with background intensity 
subtracted for each individual picture.  Statistical comparisons (two-way ANOVA, one-way 
ANOVA with post-hoc Tukey’s multiple comparisons test, and unpaired t-test) were performed 
using GraphPad Prism 7 software.  For each experiment, n>20 per strain repeated in triplicate. 
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Table 5.1. C. elegans strains used in this study 
Strain Name Genotype 
N2 wild type 
BW1490 ctIs40[dbl-1(++) + sur-5::gfp] 
BX106 fat-6(tm331) 
BX153 fat-7(wa36) 
BX156 fat-6(tm331);fat-7(wa36) 
CB678 lon-2(e678) 
CB1370 daf-2(e1370) 
CS24 sma-3(wk30) 
CS152 sma-3(wk30);qcIs6[sma-3p::gfp::sma-3 + rol-6(su1006)] 
CS619 sma-3(wk30);qcIs59[vha-6p::gfp::sma-3 +rol-6(su1006)] 
CS626 dbl-1(wk70);adIs2122[lgg-1p::gfp::lgg-1 + rol-6(su1006)] 
CS627 lon-2(e678);adIs2122[lgg-1p::gfp::lgg-1 + rol-6(su1006)] 
CS628 sma-3(wk30);qcIs55[vha-7p::gfp::sma-3 + rol-6(su1006)] 
CS630 sma-3(wk30);qcIs53[myo-3p::gfp::sma-3 + rol-6(su1006)] 
CS633 sma-3(wk30);wwEx63[ins-4p::gfp + unc-119(+)] 
CS661 daf-2(e1370);dbl-1(wk70);adIs2122[lgg-1p::gfp::lgg-1 + rol-6(su1006)] 
CS663 sma-3(wk30);ins-4(ok3534) 
CS667 ctIs40[dbl-1(++) + sur-5::gfp];ldrIs1[dhs-3p::dhs-3::gfp + unc-76(+)] 
CS668 dbl-1(wk70);ldrIs1[dhs-3p::dhs-3::gfp + unc-76(+)] 
DA2123 adIs2122[lgg-1p::gfp::lgg-1 + rol-6(su1006)] 
HT1693 unc-119(ed3);wwEx63[ins-4p::gfp + unc-119(+)] 
LD1 ldIs7[skn-1b/c::gfp + rol-6(su1006)] 
LIU1 ldrIs1[dhs-3p::dhs-3::gfp + unc-76(+)] 
LT121 dbl-1(wk70) 
MAH14 daf-2(e1370);adIs2122[lgg-1p::gfp::lgg-1 + rol-6(su1006)] 
RB2544 ins-4(ok3534) 
TJ356 zIs356[daf-16::daf-16a/b::gfp + rol-6(su1006)] 
  daf-2(e1370);lon-2(e678) 
  daf-2(e1370);sma-3(wk30) 
  daf-2(e1370);ldrIs1[dhs-3p::dhs-3::gfp + unc-76(+)] 
  daf-2(e1370);dbl-1(wk70);ldrIs1[dhs-3p::dhs-3::gfp + unc-76(+)] 
  daf-2(e1370);lon-2(e678);adIs2122[lgg-1p::gfp::lgg-1 + rol-6(su1006)] 
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5.C. Body Size Measurement 
Animals were collected at the L4 stage and anesthetized with sodium azide.  The worms were 
then imaged using a QImaging Retiga EXi camera with QCapture software.  The midline of each 
worm was then measured in ImagePro.  Statistical comparisons (one-way ANOVA with post-hoc 
Tukey’s multiple comparisons test, two-way ANOVA, and unpaired t-test) were performed using 
GraphPad Prism 7 software.  For each experiment, n>30 per strain repeated in triplicate. 
5.D. Electron Microscopy 
Animals were fixed and embedded by standard methods (Hall 1995).  Fixation and microscopy 
was performed by the David H Hall lab.  Animals were well-fed adults grown at 20°C.  Animals 
were fixed 2 days post-egg laying. 
5.E. Lipid Droplet Morphology 
Animals were collected at the L4 stage and anesthetized with sodium azide.  The worms were 
then imaged using a Zeiss ApoTome with AxioVision software.  Images were taken using a 
100X objective.  The tail region of the worm was imaged and the diameter and count of all 
visible lipid droplets in a 400µm2 area were measured using AxioVision software.  Statistical 
comparisons (one-way ANOVA with post-hoc Tukey’s multiple comparisons test, two-way 
ANOVA with post-hoc Holm-Sidak’s multiple comparisons test, and unpaired t test with 
Welch’s correction) were performed using GraphPad Prism 7 software.  For each experiment, 
n>15 per strain repeated in triplicate. 
 
 
MATERIALS AND METHODS 
104 
 
5.F. Pharyngeal Pumping Rate 
Pumping rate was counted by the number of contractions of the pharyngeal bulb per 20 seconds.  
Two counts were made per worm and averaged.  n>10 per strain repeated in triplicate. Statistical 
comparisons (unpaired t test with Welch’s correction) were performed using GraphPad Prism 7 
software.   
5.G. Dauer Formation Assay 
Five to ten L4 animals were placed per plate to lay eggs overnight at 15°C.  Adults and L1s were 
removed on the subsequent day with M9.  Plates with remaining eggs were then placed at either 
20°C or 25°C to develop.  Animals were then observed 48 hours later; dauer larvae were tallied 
versus non-dauer larvae.  Statistical comparisons (unpaired t test and two-way ANOVA) were 
performed using GraphPad Prism 7 software.  n>50 per strain at each temperature, repeated in 
triplicate. 
5.H. GFP::LGG-1 Autophagy Assay 
Autophagy was assayed via the formation of GFP punctae as described in (Palmisano and 
Meléndez 2016).  Animals were grown at 20°C and imaged at the L3 larval stage; dauer larvae 
were not imaged or quantified.  GFP::LGG-1 punctae were counted in the seam cells of the 
hypodermis.  Images were taken using a Zeiss ApoTome with AxioVision software and a 100X 
objective.  Exposure times were kept consistent across strains within each experiment.  Statistical 
comparisons (unpaired t test and one-way ANOVA) were performed using GraphPad Prism 7 
software.  n=15 per strain, repeated in duplicate. 
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5.I. Lifespan Assay 
Animals were initially grown at 15°C until reaching the L4 larval stage.  For each strain, 120 L4 
animals were plated onto 100mm petri dishes, 20 worms per plate.  Plates were then maintained 
at 25°C for the duration of the experiment.  Animals were transferred to new plates every other 
day.  Animals killed, missing, or exhibiting the bag of worms phenotype were censored from the 
final death count.  Kaplan-Meier survival curves and Mantel-Cox log-rank statistics were 
performed using GraphPad Prism 7 software. 
5.J. INS-4p::GFP Expression 
Animals were grown at 20°C and imaged as day 1 adults.  Images were taken on a Leica 
Microsystems Confocal microscope using a 20X objective.  Camera settings were maintained 
identically between all samples and trials.  Compound images were produced from compiling Z-
stack images. n>10 per strain repeated in triplicate. 
5.K. RNA Interference 
RNAi induction and feeding were carried out as described in (Kamath et al. 2000).  L4 animals 
were placed on EZ worm plates supplemented with 1mM IPTG and 50mg/ml carbenicillin 
seeded with HT115 E. coli.  Animals were allowed to lay eggs overnight.  Adults and L1 larvae 
were removed the following day with M9.  Remaining eggs were synchronized with a 4 to 6 hour 
hatch, with the L1s being transferred to new RNAi plates.  Animals were then allowed to 
develop and subsequently assayed as per the method of the experiment.  L4440 is used as the 
empty vector control in all experiments. 
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5.L. SKN-1::GFP Localization 
Following RNAi treatement (as described above), L1 animals were raised at 15°C until the L3 
larval stage followed by a shift to 25°C to bypass the dauer induction caused by the knockdown 
of daf-2.  Animals were allowed to continue to develop overnight at 25°C.  Images were taken 
using a Zeiss ApoTome with AxioVision software and a 20X objective.  Exposure times were 
kept consistent across strains within each experiment.  GFP localization was categorized as low, 
medium, or high.  Statistical comparisons (chi-square test) were performed using GraphPad 
Prism 7 software.  n>40 per strain, repeated in duplicate. 
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A. Appendix 
A.1. Body Size Increase in Δ9 Desaturases Provides Evidence that Body Size 
and Lipid Accumulation Phenotypes are Unlinked 
 
Figure A.1. Δ9 fatty acid desaturase mutants display increased body size.  Animals 
containing mutations in any one of the three Δ9 fatty acid desaturases, fat-5, fat-6, and fat-7, 
display an increase in body length.  fat-5 mutants display a significant increase from 48 hours 
onward, while fat-6 and fat-7 display a significant increase from 72 hours onward.  As all three 
mutants display a reduction in lipid accumulation, these findings on body size indicate that the 
two phenotypes are not intrinsically linked, as dbl-1 mutants display both decreased body size 
and lipid accumulation.  Error bars denote SEM, n.s. not significant, * p<0.05, ** p<.0.01, 
*** p<0.001.  n>25 per strain, repeated in duplicate  
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A.2. Gas Chromatography Mass Spectrometry Confirms Low-fat Phenotype  
of sma-3 Mutants 
 
Figure A.2.  Loss of sma-3 results in the reduction of triacylglyceride levels.  A)  The 
proportion of TAGs to PLs is reduced in sma-3 mutants compared to wild type (N2), while daf-2 
mutants have an increased proportion of TAGs.  The increase observed in daf-2 is similar to that 
seen in daf-2;sma-3 double mutants, providing further evidence for DAF-2/IIS functioning 
downstream of DBL-1/BMP signaling in the regulation of lipid content.  Additionally, sma-3 
mutants exhibit an increase in the saturated 18C fatty (stearic, C18:0) acid compared to the 
mono-unsaturated 18C (oleic, C18:1Δ9) acid, indicating a possible reduction in the activity of 
the Δ9 fatty acid desaturases, fat-6 and fat-7; daf-2 single mutants and daf-2;sma-3 mutants 
exhibit a similar increase in oleic acid compared to stearic acid. B) The basic fatty acid 
desaturation pathway in C. elegans used to convert dietary fatty acids into complex poly-
unsaturated fatty acids (PUFAs).  The Δ9 fatty acid desaturases, fat-6 and fat-7, are responsible 
for the first desaturation event converting C18:0 to C18:1Δ9, a vital step in the production of 
PUFAs.  TAGs = triacylglycerides, PLs = phospholipids.  Data shown is from one experimental 
replicate, as the N2 data from replicates 2 and 3 did not match internal controls and could 
therefore not be utilized. 
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A.3. Lipid Accumulation via BODIPY Fluorescence Confirms High-fat 
Phenotype of ins-4 and sma-3;ins-4 Mutants; Identifes tig-2 as a Possible Lipid 
Effector 
 
Figure A.3.  sma-3;ins-4 mutants exhibit high-fat phenotype similar to ins-4 and daf-2 
mutant animals. A) Both ins-4 mutant alleles, ok3534 and tm3620, display an increase in 
BODIPY fluorescence, with sma-3;ins-4 mutants also exhibiting an increase in fluorescence 
compared to control animals.  B)  BODIPY fluorescence confimred low-fat phenotype of dbl-1 
and sma-3.  High-fat phenotype was observed in tig-2 mutant animals, another TGFβ ligand in 
C. elegans.  This observation is one of the first phenotypes seen in tig-2 mutants, as the function 
of the gene is as of yet unknown.  Asterisks across the bottom represent significance compared to 
Control, n.s. not significant, ** p<.01, *** p<.001, error bars represent SEM.  n>20 per strain, 
one experimental replicate 
Note: Current research states that vital staining of BODIPY lipophilic fluorophores localize to 
both lipid droplets and lysosome-related organelles.  Therefore, vital BODIPY cannot be used as 
a quantitative measurement of lipid accumulation, but can still be used to quickly assess 
qualitative changes before following up with fixative BODIPY, or other stains such as Oil Red O 
or Nile Red (Yen et al. 2010; Klapper et al. 2011; Li et al. 2016). 
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A.4. Conserved Metabolic Pathways Across Model Organisms 
 
Table A.1.  Conserved Metabolic Pathways Across Model Organisms. C. elegans is a 
valuable tool for the study of metabolic regulation as multiple influential pathways are conserved 
from C. elegans to humans.  Listed are the components of the BMP, Insulin/IGF-1, and mTOR 
signaling pathways and their orthologs across species.  
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